TW420661B - Preparation of lignan analogues - Google Patents
Preparation of lignan analogues Download PDFInfo
- Publication number
- TW420661B TW420661B TW83103282A TW83103282A TW420661B TW 420661 B TW420661 B TW 420661B TW 83103282 A TW83103282 A TW 83103282A TW 83103282 A TW83103282 A TW 83103282A TW 420661 B TW420661 B TW 420661B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- page
- chemical formula
- cns
- ministry
- Prior art date
Links
- 229930013686 lignan Natural products 0.000 title claims abstract 4
- 150000005692 lignans Chemical class 0.000 title claims abstract 4
- 235000009408 lignans Nutrition 0.000 title claims abstract 4
- 238000002360 preparation method Methods 0.000 title claims description 47
- 150000001875 compounds Chemical class 0.000 claims abstract description 115
- -1 lactone compound Chemical class 0.000 claims abstract description 38
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 27
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 239000001257 hydrogen Substances 0.000 claims abstract description 9
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 7
- 125000005530 alkylenedioxy group Chemical group 0.000 claims abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 239000000543 intermediate Substances 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 45
- 238000011049 filling Methods 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 14
- 230000002079 cooperative effect Effects 0.000 claims description 13
- 229920001221 xylan Polymers 0.000 claims description 5
- 150000004823 xylans Chemical class 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 229910052786 argon Chemical group 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 2
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000013589 supplement Substances 0.000 claims 2
- 241000675108 Citrus tangerina Species 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 238000004898 kneading Methods 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 abstract description 7
- 230000018044 dehydration Effects 0.000 abstract description 3
- 238000006297 dehydration reaction Methods 0.000 abstract description 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 63
- 239000000203 mixture Substances 0.000 description 62
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 58
- 238000006243 chemical reaction Methods 0.000 description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 50
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 45
- 238000003786 synthesis reaction Methods 0.000 description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 230000015572 biosynthetic process Effects 0.000 description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 101150041968 CDC13 gene Proteins 0.000 description 20
- 235000019439 ethyl acetate Nutrition 0.000 description 20
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 239000013078 crystal Substances 0.000 description 19
- 238000005481 NMR spectroscopy Methods 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 17
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 14
- 239000012267 brine Substances 0.000 description 14
- 238000001816 cooling Methods 0.000 description 14
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 150000002596 lactones Chemical class 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 229930182558 Sterol Natural products 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 10
- 150000003432 sterols Chemical class 0.000 description 10
- 235000003702 sterols Nutrition 0.000 description 10
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 210000005069 ears Anatomy 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229940125773 compound 10 Drugs 0.000 description 7
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 7
- 235000015170 shellfish Nutrition 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 150000007857 hydrazones Chemical class 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 4
- 239000011654 magnesium acetate Substances 0.000 description 4
- 235000011285 magnesium acetate Nutrition 0.000 description 4
- 229940069446 magnesium acetate Drugs 0.000 description 4
- UWTNRIHEKDEGRW-UHFFFAOYSA-N methane methanol Chemical compound [H]C[H].[H]C[H].[H]CO[H] UWTNRIHEKDEGRW-UHFFFAOYSA-N 0.000 description 4
- 229940098779 methanesulfonic acid Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 4
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 229910052722 tritium Inorganic materials 0.000 description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- HPJGEESDHAUUQR-SKGSPYGFSA-N (2s)-2-[[(2s)-5-(diaminomethylideneamino)-2-[[(2s)-1-[(2s)-5-(diaminomethylideneamino)-2-[[(2s)-2-[[(2s)-3-naphthalen-2-yl-2-(3-pyridin-3-ylpropanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]buta Chemical compound NC(=O)C[C@@H](C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=C2C=CC=CC2=CC=1)NC(=O)CCC=1C=NC=CC=1)CC1=CC=CC=C1 HPJGEESDHAUUQR-SKGSPYGFSA-N 0.000 description 2
- LJIOTBMDLVHTBO-CUYJMHBOSA-N (2s)-2-amino-n-[(1r,2r)-1-cyano-2-[4-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]phenyl]cyclopropyl]butanamide Chemical compound CC[C@H](N)C(=O)N[C@]1(C#N)C[C@@H]1C1=CC=C(C=2C=CC(=CC=2)S(=O)(=O)N2CCN(C)CC2)C=C1 LJIOTBMDLVHTBO-CUYJMHBOSA-N 0.000 description 2
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 2
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
- RRELDGDKULRRDM-UHFFFAOYSA-N 6-[2-chloro-4-nitro-5-(oxan-4-yloxy)anilino]-3,4-dihydro-1H-quinolin-2-one Chemical compound [O-][N+](=O)c1cc(Cl)c(Nc2ccc3NC(=O)CCc3c2)cc1OC1CCOCC1 RRELDGDKULRRDM-UHFFFAOYSA-N 0.000 description 2
- LDIOUQIXNSSOGU-UHFFFAOYSA-N 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[d]pyrazolo[1,5-a]pyrimidine Chemical compound CC1=NN2C(NC(CC)CC)=C3CCCC3=NC2=C1C1=CC=C(OC)C=C1Cl LDIOUQIXNSSOGU-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- GYQYBHLZTINLHA-UHFFFAOYSA-M [Br-].CCC(CC)C[Mg+] Chemical compound [Br-].CCC(CC)C[Mg+] GYQYBHLZTINLHA-UHFFFAOYSA-M 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- CSYNQJPENMOLHR-UHFFFAOYSA-N n,n-diethylethanamine;ethyl acetate Chemical compound CCOC(C)=O.CCN(CC)CC CSYNQJPENMOLHR-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229910052716 thallium Inorganic materials 0.000 description 2
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- DEEDXIVCNOOEAV-UHFFFAOYSA-N (3,4,5-trimethoxyphenyl)hydrazine Chemical compound COC1=CC(NN)=CC(OC)=C1OC DEEDXIVCNOOEAV-UHFFFAOYSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- UXKLQDCALAWFIU-VKNDCNMPSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-tetradecoxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCCCC)C1=CC=CC=C1 UXKLQDCALAWFIU-VKNDCNMPSA-N 0.000 description 1
- VGNCBRNRHXEODV-XXVHXNRLSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-6-dodecoxy-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCC)C1=CC=CC=C1 VGNCBRNRHXEODV-XXVHXNRLSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- VLXSIHLNPYRFFN-UHFFFAOYSA-N 1,4-dioxane;methanol Chemical compound OC.C1COCCO1 VLXSIHLNPYRFFN-UHFFFAOYSA-N 0.000 description 1
- VBYPENUQSSBEKQ-UHFFFAOYSA-N 1-bromohexane hydrobromide Chemical compound Br.BrCCCCCC VBYPENUQSSBEKQ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- KKGUMGWNFARLSL-UHFFFAOYSA-N 3-(bromomethyl)pentane Chemical compound CCC(CC)CBr KKGUMGWNFARLSL-UHFFFAOYSA-N 0.000 description 1
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 1
- BOCQEKBKBUOBCR-UHFFFAOYSA-N 4-(2-methyliminohydrazinyl)benzoic acid Chemical compound CN=NNC1=CC=C(C(O)=O)C=C1 BOCQEKBKBUOBCR-UHFFFAOYSA-N 0.000 description 1
- XQVKLMRIZCRVPO-UHFFFAOYSA-N 4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C12=CC=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(O)=C1N=NC1=CC=CC=C1[As](O)(O)=O XQVKLMRIZCRVPO-UHFFFAOYSA-N 0.000 description 1
- WWDQROFMFKRUIF-UHFFFAOYSA-N 4-methyl-n-(4-methylpentyl)pentan-1-amine Chemical compound CC(C)CCCNCCCC(C)C WWDQROFMFKRUIF-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- JPPFNNYAPZFMAH-UHFFFAOYSA-N N,N-dichloromethanimidamide Chemical compound ClN(C=N)Cl JPPFNNYAPZFMAH-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 241000679125 Thoron Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010069201 VLDL Cholesterol Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- ZGCYAANPRIULLW-UHFFFAOYSA-N bis(trimethylsilyl)cyanamide Chemical compound C[Si](C)(C)N(C#N)[Si](C)(C)C ZGCYAANPRIULLW-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 description 1
- 229960001058 bupropion Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- XXOJIFNTOMQNHM-UHFFFAOYSA-N carbonyl dichloride;sodium Chemical compound [Na].ClC(Cl)=O XXOJIFNTOMQNHM-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000006388 chemical passivation reaction Methods 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- WDCDAAMJNUHOIY-UHFFFAOYSA-N ethyl acetate;2-propan-2-yloxypropane Chemical compound CCOC(C)=O.CC(C)OC(C)C WDCDAAMJNUHOIY-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 150000002220 fluorenes Chemical class 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 229940062135 magnesium thiosulfate Drugs 0.000 description 1
- GFTXWCQFWLOXAT-UHFFFAOYSA-M magnesium;cyclohexane;bromide Chemical compound [Mg+2].[Br-].C1CC[CH-]CC1 GFTXWCQFWLOXAT-UHFFFAOYSA-M 0.000 description 1
- TZKHCTCLSRVZEY-UHFFFAOYSA-L magnesium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [Mg+2].[O-]S([O-])(=O)=S TZKHCTCLSRVZEY-UHFFFAOYSA-L 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- SOWRLHQNTLIORS-UHFFFAOYSA-N methyl 2-oxobut-3-enoate Chemical compound COC(=O)C(=O)C=C SOWRLHQNTLIORS-UHFFFAOYSA-N 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- SFLGSKRGOWRGBR-UHFFFAOYSA-N phthalane Chemical compound C1=CC=C2COCC2=C1 SFLGSKRGOWRGBR-UHFFFAOYSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- NLPMQGKZYAYAFE-UHFFFAOYSA-K titanium(iii) fluoride Chemical compound F[Ti](F)F NLPMQGKZYAYAFE-UHFFFAOYSA-K 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
42066 1 A7 B7 五、發明説明() 本發明係有蘭一棰裂備木聚糖糸列的化合物的新方法 及其中間產物。更詳細地,係有關有效率地裂備具有一個 烷基銅鏈的木聚糖糸列化合物的一棰方法,其包括使用提 供區選擇性反應的遇克爾加成反應》 Μ本發明方法躲備的木聚糖条列化合物在治療動眤硬 化*特別是脂肪沈滞性動脈硬化*上有用,本發明者公開 了各種化合物(日本專利公報Kokai第310634/ 1993,國際 專利公報W0 93/ 08155)。 本發明係有關製備化學式(I)所代表之化合物的一種 方法: OH 042066 1 A7 B7 V. Description of the invention () The present invention is a new method for preparing compounds of the xylan series of cyanocyanine and its intermediate products. In more detail, it relates to a method for efficiently preparing a xylan queue compound having an alkyl copper chain, which includes the use of a Hockel addition reaction that provides a regioselective reaction. The xylan streak compounds are useful for the treatment of dysplasia *, especially fatty arteriosclerosis *, and the present inventors have disclosed various compounds (Japanese Patent Publication Kokai No. 310634/1993, International Patent Publication WO 93/08155). The present invention relates to a method for preparing a compound represented by formula (I): OH 0
^ 1 J I I !..· ! n I (請先閲讀背面之注意Ϋ項再填寫本頁) 經濟部中央標準局員工消费合作社印装 其中R1是烷基*環烷基,環烷基一低级烷基*或芳烷基; 以及1^分別是低级烷基或1^及113結合起來形成烯化二氧基 t R4是低级烷氧基或氫; 以及以分別是低级烷基;及 R7是低级烷基; 其特徴在於化學式(ΙΠ所代表的内酯化合物: 本紙張尺度適用中國國家標準{ CNS ) Α4規格(210X297公釐) 6 83.3.10,000 42066: A7 B7 五、發明説明( Ο^ 1 JII! ..!! N I (Please read the note on the back before filling in this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs where R1 is alkyl * cycloalkyl, cycloalkyl-lower alkyl Or * and aralkyl; and 1 ^ is lower alkyl or 1 ^ and 113 are combined to form an alkylene dioxy group t R4 is lower alkoxy or hydrogen; and R1 is lower alkyl; and R7 is lower Alkyl group; its special feature is the lactone compound represented by the chemical formula (II): This paper size applies the Chinese National Standard {CNS) A4 specification (210X297 mm) 6 83.3.10,000 42066: A7 B7 V. Description of the invention (Ο
OR6 (Π) 其中Ra,Ra * R4,Ra&Re如上所定義,和化學式(ΠΙ) 的一種化合物反應: (I) (請先閲讀背面之注意事項再填寫本頁) r7o2c· 經濟部中央樣準扃負工消費合作社印製 其中R1及R7如上所定義,在鹼的存在下,對所產生的化合 物進行脫水。在本發明中,可Μ有效率地製備棲的化合物 。因此,本發明之方法適合作為木聚糖類似物大規模合成 的方法。 在其他方面,本發明係有關上述化合物(Π)及(III) ,其在本發明方法中是有用的。 在界定方面,R1之“烷基” 一詞係指直鐽或支鏈〇至 C,。烷基,而“低级烷基”係指直鍵或支鍵(^至“烷基如 甲基,乙基* η-丙基,異丙基,η-丁基,異丁基,二级丁 基,η-戊基,1-乙基丙基及2-乙基丁基等。“環烷基”一 本紙張尺度適用中國國家標準(CNS〉Α4規格(210X297公釐) 83. 3.10,000 A7 B7 ^2066 五、發明説明() 詞傈指C*至。環烷基如環戊基,環己基及環庚基。“琛垸 基低级烷基”一詞指一値基其中該上所定義的低级烷基具 有上述所定義的璟烷基取代基及其寊例為環己基甲基及環 戊基乙基等。“芳垸基”一詞係指一偁基其中上所定義的 垸基被一镝芳基取代,而其實例爲苄基,卜甲氧苄基,苯 乙基,苯丙基及祭甲基等。 “低级烷氧基指一値基其中氧基被上所定義的低级烷 基所取代,而其實例磊甲氧基,乙烯化二氧基及丙播化二 氧基等。OR6 (Π) where Ra, Ra * R4, Ra & Re are as defined above, and react with a compound of formula (II): (I) (Please read the precautions on the back before filling this page) r7o2c · Central Ministry of Economic Affairs Printed by the Zhuanxi Sub-consumer Cooperative, where R1 and R7 are as defined above, the produced compounds are dehydrated in the presence of a base. In the present invention, the dwelling compound can be efficiently prepared. Therefore, the method of the present invention is suitable as a method for large-scale synthesis of xylan analogs. In other aspects, the present invention relates to the aforementioned compounds (II) and (III), which are useful in the method of the present invention. In terms of definition, the term "alkyl" of R1 means straight or branched from 0 to C ,. Alkyl, and "lower alkyl" refers to straight or branched bonds (^ to "alkyl such as methyl, ethyl * η-propyl, isopropyl, η-butyl, isobutyl, secondary butyl Groups, η-pentyl, 1-ethylpropyl, 2-ethylbutyl, etc. "Cycloalkyl" is a paper size that applies to Chinese national standards (CNS> A4 specification (210X297 mm) 83. 3.10,000 A7 B7 ^ 2066 V. Description of the invention () The word 傈 means C * to. Cycloalkyl such as cyclopentyl, cyclohexyl and cycloheptyl. The term "shenyl-lower alkyl" refers to a methyl group in which The lower alkyl group defined has a fluorenyl alkyl substituent as defined above and its examples are cyclohexylmethyl and cyclopentylethyl, etc. The term "arylfluorenyl" refers to a fluorenyl group as defined above Is substituted by a monoaryl group, and examples thereof are benzyl, dimethoxybenzyl, phenethyl, phenylpropyl, methyl, and the like. "Lower alkoxy refers to monomethyl where oxy is as defined above It is substituted by lower alkyl, and examples thereof include methoxy, vinyl dioxy and propioni dioxy.
Rfl及?13的w烯化二氧基〃 一詞指Cl至C3之烯化二氧基 如甲二氧基,乙二氧播及丙二氧撐。 本發明的製備方法包括提供於下的二個步驟: 步驟1 I.,I I---- I T— — 装—-----訂 (請先M讀背面之注$項再填寫本頁) 0The term w-alkylenedioxyfluorene of Rfl and? 13 refers to alkylenedioxy groups such as methyldioxy, ethylenedioxy and propylenedioxy from Cl to C3. The preparation method of the present invention includes the following two steps provided: Step 1 I., I I ---- IT—— — 装 —----- Order (please read the note on the back before filling in this page ) 0
.Λ r7〇2c OR6 鹼 (ill) H〇 〇.Λ r7〇2c OR6 base (ill) H〇 〇
經濟部中央樣準局員工消費合作杜印褽 步驟2 H〇 〇Du Yinye, Consumer Co-operation of the Central Sample Bureau of the Ministry of Economic Affairs Step 2 H〇 〇
酸acid
OH OOH O
(ί) 本紙張尺度通用t國國家標準(CNS ) A4規格(210父297公嫠> 8 83.3.10,000 經濟部中央標準局員工消費合作社印衷 ^2066 1 a? _B7_______五、發明説明() 第1步躱中* 一内酯(II)及一不跑和酮(πι)在一種 鹸的存在下反睡而生成化合物(IV)。 第2步斑中,以睃處理將化合物(IV)脫水而生成所要 的化合物(I)。 反_婼伴 在第1步栽中所用的化合物(丨1)對化合物(IIU的比 例方面並無特別限制,但U π )通常以超過化合物(〗丨)的 貴使用,較佳是1 : 1至1 : 2。 在此步驟所用的鹼的實例是一般的二烷基金屬醢胺類 如二異丙基酿胺鋰,及二異己基醯胺鈉等I及雙對(三烷 基甲矽烷基)金屬醢胺類如雙對(三甲基甲矽氧基)醯胺納 等。較佳是使用雙對(三甲基甲矽氧基)醯胺鋰。 有關反應溶劑方面,可單獨或组合方式使用如四氫呋 喃,二乙醚及二噁烷之K類,如Π-己烷及Π-戊烷之磺氫化 合物;如苯及甲笨之芳番碳氫化合物;如二氣甲烷之鹵化 磺氫化合物;及如N,N-二甲基甲醯胺及六甲基磷酸三睦 胺之醱胺類。較佳的溶劑是四氫呋喃,二氯甲烷,Ν’,N-二甲基甲酿胺及六甲基磷酸三醯胺》 此步驟之反應通常在-100¾至100Ό (較佳自-801:至 室溫)及在數分鏟至數小時内完成。 用於第2步驟的酸的實例爲如g氯酸,硫酸,三氟乙 酸,磺酸(甲磺酸* P~甲苯磺酸)之有機酸或無機酸*或路 易士醚(三氟化硼或三氣化钛等)。較桂是使用三氟化棚或 甲磺酸。在酸的董方面沒有特定的限制,但較佳是使用1 (請先閲讀背面之注意事項苒填寫本頁) '17 本紙張尺度適用中國國家橾準(CNS ) Μ規格(210X297公釐) 9 83.3. 10,000 經濟部t夬標準局員工消費合作社印裝 ^2^661 A7 B7五、發明説明() 至2等量。. 有鼷反應的溶劑,可使用如苯及甲苯之芳香碩氫化合 物;如二氣甲烷之齒化联氫化合物;如乙腈的腈類。 此步驟的反應一般在-70 t至1001C (較佳-20t至室 溫)在數份鏟至數小時内完成。 本發明的内酯(1Π及該不飽和嗣(III),同時也是本 方法之啟姶物質*能自已知化合物製備,例如,藉由下列 的躲備方法。 本發明將Μ下列的裂備及工作實例作進一步的說明, 然而其非用來限制本發明的範圍。 仆.会物Π Π夕合成音梱 第势備 合成3-(3,4-二甲氧基苯基卜4, 5, 6-三甲氧基-1(3 H)-異苯並呋喃g旨:II-1 第1步—斑合成4,4-二甲基-2-(3,4 * 5-三甲氧基苯基) -2-噁唑啉:2。 在冰浴冷郤下,將500克(2.17莫耳)3, 4, 5-三甲氧 基苯醯氮(化合物1 >在1升乾二氣甲烷中的溶液以2小時 的時間逐滴加到386克(4.34其耳)2-氨基-2-甲基-卜丙醇 在1升乾二氯甲烷的溶液中。在添加完成後,將混合物再 .攪拌1小時及將該反應溶液過濾通過一玻璃濾器。用500 Bl二氯甲烷沖洗逋拼,將濾液和該沖洗液結合,然後在真 空下灌縮。將殘餘物懸浮在900al乾甲苯及100ml乾二氯甲 烷之混合物中,及在冰浴冷卻下將206®1(2.82毫莫耳)的 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家搮準(CNS ) A4規格(210X:297公釐) «3. 3.10,000 420661 經濟部中央榇準扃舅工消费合作社印策 A7 B7_五、發明説明() 亞硫醯氣逐滴加入。在繼續搜拌30分鐘時,讓該混合物回 溫至室溫。然後*用冰浴將該混合物再度冷卻,及加入 200·1的水及氫氧化銷水溶液(500克的NaOH在1.8升的水中 )。然後Μ甲苯萃取該混合物。該萃取物Μ水及鹽水神洗 ,然後Μ無水硫酸鎂乾燥。在真空中濃缩後,將殘餘物自 二氣甲烷-η-己烷(200毫升-2.0升)中結晶化,而得所要的 Ϊ惡唑啉495克作為第一結晶,及61克作為第二結晶。總產 量:565克(自化合物1為%.5¾)。熔點:87-891:。 l-NMR: δ (CDCU)1.39<6H,s)3,88(3H,s)3.91 (6H,s)4.10(2H,s)7.20<2H,s)。 笛2击趣 合成化合物Π -1 在氮氣流下*將1.66Ν η-丁基鋰的己烷溶液(800βΠ ; 1.33其耳)以1小時15分鐘的時間逐滴加至355克(1.26其 耳)上述所得的噁唑啉(化合物2 )在1.7升乾THF,其Μ冷 凍劑冷卻在-35至-401,的溶液中。在添加完成後,將該 混合物在-20至-35C再攪拌1小時,然後冷卻至-78t, 及逐滴加入231克(1.39莫耳* 1.10當量)3, 4-二甲氧基苯 醛在500ml乾THF的溶液。添加完成後,以冰浴取代冷卻 -浴,将該混合物攪拌1小時。然後,加人400nl飽和氯化 銨水溶液及400»1的水,該混合物以已酸乙酯萃取。萃取 物以水及豳水清洗,Μ無水硫酸鎂乾燥及在真空室中濃縮 。將殘餘物溶於丨.4升的10%硫酸,及將該混合物在回滾 下加熱40分鐘。將冰水加到反應溶液中,及以過濾方式收 (請先閲讀背面之注$項再填寫本頁) 本紙柒尺度適用中國國家標準(CNS } Α4規格(2丨0 X 297公釐) 83. 3.10,000 4 2 Ο 6 6 A7 B7 五、發明説明() 集沈澱的晶體。將晶體溶於1.5升的二氯甲烷中,用水洗 ,以無水较酸鎂乾燒,然後在真空中狼缩。殘餘物自二氣 甲垸一甲辞中再结晶而得390克(自化合物2為85.7¾)的 所要的内酯Π-1。熔點為141-142¾。 ^H-NMR: 8 (CDCla)3.52(3Η > s)3.83(3H> s)3.89 (3H,s)3‘92<3H,s)3.95(3H,s>6.32(1H,s)6.72UH, s)6.86(2H ' s)7.21(1H,s)。 第1製備的反應M下列的滾程表示。(ί) The national standard (CNS) A4 specification of this paper standard (210 father 297 public 嫠 > 8 83.3.10,000 Employee Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 印 2066 1 a? _B7_______ V. Description of the invention ( ) In step 1 *, a lactone (II) and a ketone (πι) are slept back in the presence of a hydrazone to form the compound (IV). In the second step, the compound (IV) is treated with 睃) Dehydration to produce the desired compound (I). The compound (丨 1) used in the first step is not particularly limited in terms of the ratio of the compound (IIU, but U π) usually exceeds the compound (〗丨) expensive use, preferably 1: 1 to 1: 2: Examples of the base used in this step are general dialkyl metal amines such as lithium diisopropylamine, and diisohexylamine I, sodium, etc. and bis- (trialkylsilyl) metal amines such as bis- (trimethylsilyl) cyanamide, etc. It is preferable to use bis- (trimethylsilyl) Lithium amine. For the reaction solvent, it can be used alone or in combination, such as K type of tetrahydrofuran, diethyl ether and dioxane, such as Π-hexane And Π-pentane sulfohydrogen compounds; such as benzene and methylbenzyl aromatic hydrocarbons; such as digas methane halogenated sulfohydrogen compounds; and such as N, N-dimethylformamide and hexamethyl phosphate tris The best solvents are amines. The preferred solvents are tetrahydrofuran, dichloromethane, N ', N-dimethylformamide and trimethylamine hexamethyl phosphate. The reaction in this step is usually -100¾ to 100Ό (compared with Best from -801: to room temperature) and completed within a few minutes to several hours. Examples of acids used in the second step are such as g chloric acid, sulfuric acid, trifluoroacetic acid, sulfonic acid (methanesulfonic acid * P ~ Toluenesulfonic acid) organic or inorganic acid * or Lewis ether (boron trifluoride or titanium trifluoride, etc.). It is more trivalent or trifluorinated shed or methanesulfonic acid. There are no specific restrictions on the aspect of the acid. , But it is better to use 1 (please read the precautions on the back and fill in this page) '17 This paper size is applicable to China National Standards (CNS) M specifications (210X297 mm) 9 83.3. 10,000 Ministry of Economic Affairs t 夬 Standards Bureau Printed by the employee consumer cooperative ^ 2 ^ 661 A7 B7 V. Description of the invention () to 2 equal amounts .. Solvents with a hydrazone reaction, such as benzene and formazan Aromatic aromatic compounds of benzene; such as dihydric compounds of digas methane; nitriles such as acetonitrile. The reaction in this step is generally from -70 t to 1001C (preferably -20t to room temperature) in several parts to several shovel. Completed within hours. The lactone (1Π and the unsaturated hydrazone (III) of the present invention, which is also the starting material of the method * can be prepared from known compounds, for example, by the following evasion method. The present invention will The cleavage preparation and working examples are further described, but it is not intended to limit the scope of the present invention. The synthesizer Π Π synthesizes the sound potential and synthesizes 3- (3,4-dimethoxyphenylbubble 4, 5, 6-trimethoxy-1 (3 H) -isobenzofuran g Purpose: II-1 Step 1—Spot synthesis of 4,4-dimethyl-2- (3,4 * 5-trimethyl (Oxyphenyl) -2-oxazoline: 2. Under ice-cooling, a solution of 500 g (2.17 moles) of 3, 4, 5-trimethoxyphenylhydrazine (Compound 1 > in 1 liter of dry digas methane) was added dropwise over a period of 2 hours. To a solution of 386 g (4.34 mils) of 2-amino-2-methyl-propanol in 1 liter of dry dichloromethane. After the addition was complete, the mixture was stirred again for 1 hour and the reaction solution was filtered through A glass filter. Rinse the mixture with 500 Bl dichloromethane, combine the filtrate with the rinse solution, and then shrunk under vacuum. Suspend the residue in a mixture of 900al dry toluene and 100ml dry dichloromethane, and ice Under bath cooling, 206®1 (2.82 millimolar) (Please read the precautions on the back before filling this page) This paper size applies to China National Standard (CNS) A4 (210X: 297 mm) «3. 3.10,000 420661 Instruction A7 B7_7, Central Cooperative Consumers' Cooperative of the Ministry of Economic Affairs V5. Description of the invention () Thiophane gas is added dropwise. While continuing to search for 30 minutes, allow the mixture to warm to room temperature. Then * the mixture was cooled again in an ice bath, and 200 · 1 of water and an aqueous hydroxide solution (500 g NaOH in 1.8 liters of water). The mixture was then extracted with toluene. The extract was washed with water and brine, and then dried over anhydrous magnesium sulfate. After concentration in vacuo, the residue was taken from methane-η-hexane. It crystallized in alkane (200 ml-2.0 liters) to obtain 495 g of the desired oxazoline as the first crystal and 61 g as the second crystal. Total yield: 565 g (from Compound 1 to 5%). Melting point: 87-891: l-NMR: δ (CDCU) 1.39 < 6H, s) 3,88 (3H, s) 3.91 (6H, s) 4.10 (2H, s) 7.20 < 2H, s). Flute 2 quasi-synthetic compound Π-1 Under nitrogen flow * 1.66N η-butyllithium in hexane solution (800βΠ; 1.33 its ears) was added dropwise to 355 g (1.26 its ears) over a period of 1 hour and 15 minutes. The oxazoline (compound 2) obtained above was dissolved in 1.7 liters of dry THF, and its M refrigerant was cooled to -35 to -401. After the addition is complete, the mixture is stirred for an additional hour at -20 to -35C, then cooled to -78t, and 231 grams (1.39 mole * 1.10 equivalent) of 3,4-dimethoxybenzaldehyde are added dropwise at 500 ml of dry THF solution. After the addition was complete, the cooling-bath was replaced with an ice bath, and the mixture was stirred for 1 hour. Then, 400 nl of a saturated ammonium chloride aqueous solution and 400 »1 of water were added, and the mixture was extracted with ethyl acetate. The extract was washed with water and tritium water, dried over anhydrous magnesium sulfate and concentrated in a vacuum chamber. The residue was dissolved in 1.4 liters of 10% sulfuric acid, and the mixture was heated under rolling for 40 minutes. Add ice water to the reaction solution, and collect it by filtration (please read the note on the back before filling this page) The paper's dimensions apply to the Chinese national standard (CNS) Α4 size (2 丨 0 X 297 mm) 83 3.10,000 4 2 Ο 6 6 A7 B7 V. Description of the invention () Collect the precipitated crystals. Dissolve the crystals in 1.5 liters of dichloromethane, wash with water, dry dry with anhydrous magnesium acid, and then wolf in vacuum. The residue was recrystallized from dichloroformamidine to obtain 390 g (85.7¾ from compound 2) of the desired lactone Π-1. The melting point was 141-142¾. ^ H-NMR: 8 (CDCla ) 3.52 (3Η > s) 3.83 (3H > s) 3.89 (3H, s) 3'92 < 3H, s) 3.95 (3H, s > 6.32 (1H, s) 6.72UH, s) 6.86 (2H 's ) 7.21 (1H, s). The reaction M prepared in the first step is shown in the following rolling range.
MeO MeO )pfC〇C, 〇Tci2MeO MeO) pfC〇C, 〇Tci2
OHOH
MeO 1 2 ) SOCI2 PhMe CH2CI2MeO 1 2) SOCI2 PhMe CH2CI2
-----J-----y---裝------訂 (請先閲讀背面之注意事項再填寫本頁)----- J ----- y --- install ------ Order (Please read the precautions on the back before filling this page)
1 )n-BuLi/THF MeOCHO MeO 2 ) 10% H2S04 經濟部中央標準局員工消費合作社印製1) n-BuLi / THF MeOCHO MeO 2) 10% H2S04 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
OMe mp.mm 合成3-(3, 4-二甲氧基苯基)5, 6-甲二氧基-1(3H)-異苯 並呋喃酯··丨1-2。 步揉合成2-(3,4-二甲氧基-α -羥基苄基)4,5-甲 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 12 83. 3. 10,000 42066 丨 A7 B7 經濟部中央標準局員工消費合作社印裝 五、發明説明() 二氧基苯醛乙烯化二氧基乙縮醛:4。 (U在28.0克(122¾莫耳)2-溴-4,5-甲氧基苯醛(化 合物3 )士 250毫升的苯之溶液中加人乙二醇(14·1)及465 mg的Ρ-甲苯磺酸,及將該混合物在回滾下加熱3小時Μ利 用J-斯逹克(Dean-Stark)汽水閥芫成脫水作用。在冰浴中 冷卻後,在反應溶液中加入飽和的重硪酸納水溶液,及用 乙酸乙酯萃取該混合物。該萃取物用水及鹽水清洗,以無 水硫酸_乾燥,及在真空中濃縮而得33.2克晶體狀之乙縮 醛粗產物。此產物不經進一步純化即用於下一値反應。 (ii)在気氣滾下,將1.64N η-丁基鋰在η-己烷(80nl) (131毫其耳)的溶液逐滴加到在78¾之33.2克上述得到的 粗乙縮醛在300ml乾TH卩之溶液中。在相同溫度组绪搜拌 30分鑊後,加入20.3克(122毫冥耳)3,4-二甲氧基苯醛在 85ιπ1乾THF中的溶液,將該混合物再攪拌30分鐘。將飽和 的氯化銨水溶液加到反應溶液中,再以乙眩乙酯萃取該混 合物。萃取物以水及鹽水清洗,以無水碕駿鎂乾燥及在真 空中濃縮。殘餘物用中壓力矽膠管柱色層分祈法(600克 Si〇e ;乙酸乙酯:η-己烷=1 : 2至1 : 1)純化,而得油狀 之35.6克所要的化合物4 (自化合物3為80.9%)。 •H-NMR: δ (CD30D)3.77(3H . s)3.80(3H,s)3.9〇-4.17(4H,B)5.91(lH.d,J=1.2Hz)5‘93(lH, d, J=1.2 Hz)5.97(lH,s>6.13(lH,s>6‘85(lH,s)6.87(lH,s) 6-8δ(1Η,s)6.98(1H,s)7.02( 1H,s)。 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 13 81110,000 420661 經濟部中央標準局負工消費合作社印裝 A7 B7_五、發明説明() 绝2击發合成2-(3,4-二甲氧基~α-乙醯氧基笮基) -4,5_甲氧基苯醛:5。 (i) 在気氣流下,在冰浴冷卻下將醋酸酐(12. l»i ; 128毫其耳)加至35.6克(98.3毫其耳〉的上所得的化合物4 ,360克N,N-二甲基氨基lift聢及2U1的三乙基胺在170ml 乾THF的溶液中。在邋拌該混合物50分鐘之同時,讓其囬 溫至室溫。加入甲醇(4.4ml ),將該混合物攪拌20分鐘及 在真空中濃编。將水加至殘餘物上及用乙酸乙醋萃取之。 萃取物用水及强水清洗,Μ無水碇酸鎂乾棟,及在真空中 濃縮而得39.6克油狀之所要乙酸鹽類的粗產物。此不需進 一步的純化即用於下一個反應。 (ii) 在39.6克上所得的乙酸鹽類粗產物在35〇111丙_ 的溶液中,在冰浴冷卻下加入35b1 N之氫氣酸。當被擬 拌1小時之同時,讓混合物回溫至室溫。藉由添加飽和的 重碳酸鈉水溶液而中和該反應混合物,及在真空中濃縮。 將水加至殘餘物上及用乙酸乙酯萃取。萃取物用水及鹽水 清洗,Μ無水硫酸鎂乾燥及在真空中乾燥,而得39.0克所 要醛5的油狀之粗產物。此未經進一步純化即用於下一艏 反蘸。 ^-NMR: δ (CDC13)2. 16(3Η . s) 3.85 (6Η , s) 6.09 (2H,s)6.80_6.89(3H,ιη〉7·09(1Η,s〉7.32(lH,s)7.58 (1H , s) 〇 {請先M讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3.10,000 42066 1 A7 B7 五、發明説明() 第3步-班合成化合物Π-2 上所得的醛5之粗產物(39.0克)溶於500nl甲醇及250 1的二嗯烷中,然後加入130b1 2-甲基-2 丁烯。然後加入 250b1之44克<486毫其耳)亞氣酸納57克(365毫莫耳)二氫 磷酸納的水溶液,在室溫中將混合物攪拌20分鐘。在添加 5N氫氧化納水溶液(160«il>至反應溶液後,携拌該混合物 25分鐘,然後加入160ιβ1 6Ν氫氯酸,接箸再攪拌20分鐘 。將冰水加入反應溶液中,及用二氣甲烷萃取該混合物。 該萃取物用水》飽和的重磺酸鈉水溶液及鹽水清洗,以無 水硫酸鎂乾燥。在真空中濃縮之後,以醚清洗結晶狀的粗 殘餘物.然後自甲醇中再結晶而得27克(自化合物4為86.2 % )晶體狀之所要的内酯11-2。熔點:Π6-178Τ:。 δ (CDC1 ,)3.83(3Η » s)3.89(3Η,s)6. 12 (2Η, ΑΒ 型 * J=1.2Hz)6.20(lH,s〉6.66(2H,d,J=1.2Hz) 6.86(1H,s)6.87(1H,s)7.25( 1H,s)。 第2裂備之上述反窸Μ下列流程來表示 ί---„--------1;------訂 (請先閩讀背面之注意事項再填寫本頁) 經濟部t央標隼局員工消費合作、杜印装 carOMe mp.mm Synthesis of 3- (3,4-dimethoxyphenyl) 5, 6-methyldioxy-1 (3H) -isobenzofuran ester 1-2. Step-by-step synthesis of 2- (3,4-dimethoxy-α-hydroxybenzyl) 4,5-methyl This paper is sized to the Chinese National Standard (CNS) A4 (2 丨 0X297 mm) 12 83. 3. 10,000 42066 丨 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention () Dioxybenzaldehyde ethylenedioxyacetal: 4. (U To a solution of 28.0 g (122¾ mole) of 2-bromo-4,5-methoxybenzaldehyde (compound 3) and 250 ml of benzene was added ethylene glycol (14 · 1) and 465 mg of P -Toluenesulfonic acid, and the mixture was heated under rollback for 3 hours. Using a Dean-Stark soda valve, dehydration was effected. After cooling in an ice bath, a saturated weight was added to the reaction solution. Aqueous sodium acetate solution, and the mixture was extracted with ethyl acetate. The extract was washed with water and brine, dried over anhydrous sulfuric acid, and concentrated in vacuo to obtain 33.2 g of a crude acetal product as a crystal. This product was not subjected to Further purification was used for the next reaction. (Ii) A solution of 1.64N η-butyllithium in η-hexane (80nl) (131 mils) was added dropwise to 78 ¾ under a tritium roll. 33.2 g of the crude acetal obtained above was dissolved in 300 ml of dry TH solution. After 30 minutes of mixing at the same temperature, 20.3 g (122 mmol) of 3,4-dimethoxybenzaldehyde was added in 85 μπι of a solution in dry THF, and the mixture was stirred for another 30 minutes. A saturated ammonium chloride aqueous solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The extract was washed with water and brine, dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was subjected to a medium pressure silica gel column chromatography (600 g SiOe; ethyl acetate: η-hexane). Hexane = 1: 2 to 1: 1) purification to obtain 35.6 g of the desired compound 4 (80.9% from compound 3) as an oil. • H-NMR: δ (CD30D) 3.77 (3H.s) 3.80 (3H , s) 3.90-4.17 (4H, B) 5.91 (lH.d, J = 1.2Hz) 5'93 (lH, d, J = 1.2 Hz) 5.97 (lH, s > 6.13 (lH, s > 6 ' 85 (lH, s) 6.87 (lH, s) 6-8δ (1Η, s) 6.98 (1H, s) 7.02 (1H, s). (Please read the precautions on the back before filling out this page) The paper size applies China National Standard (CNS) A4 specification (210X297 mm) 13 81110,000 420661 Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7_V. Description of the invention () Must be 2 shots to synthesize 2- (3, 4- Dimethoxy ~ α-ethoxyfluorenyl) -4,5-methoxybenzoaldehyde: 5. (i) Under a thallium stream, the acetic anhydride (12. l »i; 128 mils) to 35.6 g (98.3 mils) of the compound 4, 360 g of N, N-dimethylamino lift (R) and 2U1 triethyl In 170ml of dry THF was at the same time of 50 minutes and the mixture was stirred slovenly, allowed to warm to room temperature. Methanol was added (4.4 ml), and the mixture was stirred for 20 minutes and concentrated in vacuo ed. Water was added to the residue and it was extracted with ethyl acetate. The extract was washed with water and strong water, dried over anhydrous magnesium acetate, and concentrated in vacuo to obtain 39.6 g of the crude product of the desired acetate as an oil. This was used in the next reaction without further purification. (ii) To a solution of 39.6 g of the crude acetate product in 350.11 propionol, 35b1 N hydrogen acid was added under cooling in an ice bath. While being stirred for 1 hour, allow the mixture to warm to room temperature. The reaction mixture was neutralized by adding a saturated aqueous sodium bicarbonate solution, and concentrated in vacuo. Water was added to the residue and extracted with ethyl acetate. The extract was washed with water and brine, dried over anhydrous magnesium sulfate and dried in a vacuum to obtain 39.0 g of an oily crude product of the desired aldehyde 5. This was used without further purification for next dip. ^ -NMR: δ (CDC13) 2. 16 (3Η. S) 3.85 (6Η, s) 6.09 (2H, s) 6.80_6.89 (3H, ιη> 7 · 09 (1Η, s> 7.32 (lH, s ) 7.58 (1H, s) 〇 {Please read the notes on the back before filling in this page) This paper size applies to China National Standard (CNS) A4 (210X297mm) 83. 3.10,000 42066 1 A7 B7 V. Explanation of the invention () Step 3-The crude product of the aldehyde 5 (39.0 g) obtained from the compound Π-2 was dissolved in 500 nl of methanol and 250 1 of dioxane, and then 130b1 2-methyl-2 butene was added Then, an aqueous solution of 57 g (365 mmol) of sodium dihydrogenate (44 g < 486 mmol) of 250b1 sodium phosgene was added, and the mixture was stirred at room temperature for 20 minutes. After adding a 5N sodium hydroxide aqueous solution (160 «il > to the reaction solution, stir the mixture for 25 minutes, then add 160 μβ1 6N hydrochloric acid, and then stir for 20 minutes. Add ice water to the reaction solution, and use two The mixture was extracted with gaseous methane. The extract was washed with water> saturated aqueous sodium disulfonate solution and brine, and dried over anhydrous magnesium sulfate. After concentration in vacuo, the crystalline crude residue was washed with ether. It was then recrystallized from methanol 27 g (86.2% from compound 4) of the desired lactone 11-2 in the form of crystals were obtained. Melting point: Π6-178T: δ (CDC1,) 3.83 (3Η »s) 3.89 (3Η, s) 6. 12 (2Η, AB type * J = 1.2Hz) 6.20 (lH, s> 6.66 (2H, d, J = 1.2Hz) 6.86 (1H, s) 6.87 (1H, s) 7.25 (1H, s). 2nd split The following procedures are prepared to indicate the above-mentioned anti-failure, which means: ----------- 1; ------ Order (please read the precautions on the back before filling out this page) Standards Bureau employee consumer cooperation, Du printed car
1 ) HO ( CH2 )2〇H TsOH (cat.) PhH1) HO (CH2) 2〇H TsOH (cat.) PhH
2)n-Βυϋ/THF MeO-^~^-CHO MeO 0·2) n-Βυϋ / THF MeO- ^ ~ ^ -CHO MeO 0 ·
本紙張尺度適用中國國家標準(CNS >Α4規格(210X297公釐) 83. 3.10,000 ?Π00 1 Α7 87 五、發明説明() t)AC2〇,Et3N OMAP/THF 2)1NHCIi 丙酮This paper size applies Chinese national standard (CNS > A4 specification (210X297 mm) 83. 3.10,000? Π00 1 Α7 87 V. Description of the invention () t) AC2〇, Et3N OMAP / THF 2) 1NHCIi acetone
NaCI02· NaH2P〇4· 水溶液MeOH-二噁烷NaCI02 · NaH2P〇4 · Aqueous solution MeOH-dioxane
ΟΜ· OMe _ 水蹲液NaOH; 6N HC1 M 化合物(III)可M下列提供之三棰方法中之任一棰製 備。 經濟部中央標準局貝工消費合作社印製 卸櫥仆,会物(1丨1):>第1種方法 笛3剪備 合成甲基(E)-4-環己基〜4-氧-2-丁烯酯: 笛1逬癍合成3-頊己基-5-(甲氧基羰基)-2-異噁唑 啉:8a。 U)在冰浴冷卻下,將224克(2.00其耳)環己烷羧基醛 (化合物6a>在133ml 99%乙醇中的溶液逐滴加到800π 1的 154克(2.2莫耳)氩氣羥基胺及166克U. 20其耳)磺酸鉀的 水溶液。在添加完成後,在邋拌1小時的同時讓該混合物 回溫至室溫,然後用900ml的乙酸乙酯萃取。萃取物用水 及馥水清洗,而得所要的肟在乙酸乙醋中的溶液。 (ii)在冰浴冷卻下,上述所得在乙酸乙酯中的肟溶液 ,含有200nl (2.40其耳)丙烯甲酯,溶液逐滴加至3升約 10%次氣酸鈉(約4冥耳)水溶液及28ι»1 (200毫其耳)三乙 基胺的混合物,及劇烈地!S拌2小時。在添加完成後,在 搜拌1小時的同時讓該混合物回溫到室溫,然後用乙酸乙 II-----I--:--装 ^------訂 (請先W讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 83.3. 10,000 A7 B7 42〇66 1 ----- 五、發明説明() 酯萃取。該萃取物用及發水清洗*以無水硫睃鎂乾操*及 在真空中濃縮而得369克油狀的異噁睡啉(化合物8 )的粗 產物(自化合物6a為88% )。 *H-NMR: δ (CDCU) 1. 10-1. 45(5Η - m) 1. 48-1. 90 (5H,m)2_35-2.50(lH,m)3.19UH,d,J=8.2Hz)3.20 (1H,d,J=9.4Hz)3.79(3H,s)4.96(lH,dd,J=8.2Hz ,94Hz)。 笛2击思 合成化合物I Π-a。 (i〉將上所得的異噁唑啉(化合物8a)的粗產物(369克) 溶於1.5升甲醇* 316 ml水及474 ml乙酸的混合物中,在 11.1克10%耙-碳存在及在氫氣下,在室溫攪拌該混合物 6小時。將鈀-碳過濾除去,及將濾液在真空中濃缩。在 殘餘物中加入水,以乙酸乙酯萃取該混合物。該萃取物用 水*飽和重碳酸納水溶液及鹽水淸洗,以無水硫酸鎂乾燥 ,及在真空中乾燥而得280克油狀的所要之羥基酮之粗產 物。 (ii>在冰浴冷郤下,將163ml (2. 10其耳)甲烷磺睦氣 Μ 1小時的時間逐滴加入280克上所得的粗羥基阑及8 19mi (5.89其耳)三乙基胺在1.4升乾乙酸乙酯的溶液中。在攪 拌1小時的同時,讓該混合物回溫至室溫。在添加冰水後 * Μ濃氫氯酸酸化詼混合物* Μ及乙酸乙酯萃取。該萃取 物Κ水,飽和的重磺酸納水溶液及鹽水清洗,Μ無水碇酸 鎂乾燥,及在真空中澴縮。自80%乙醇水溶液結晶該殘餘 I. I ϋ r— I In I— * n . n n n n In、1T (請先w讀背面之注意事項再填寫本頁) 經濟部中央標隼局貝工消費合作社印裝 本紙涑尺度適用_國國家標準(€阳)六4说格(:210/297公釐) 83.3.10,000 42066 1 經濟部中央標準局員工消費合作社印繁 A7 B7 _五、發明説明() 物,而得158克不跑和的酹酯结晶(自化合物8a為62% >。 熔酤:53-56*0。 *H-NMR: δ (CDCU) 1.10-1.50 (5H . m) 1.60-2.00 <5H,b)2.50-2,63(1H, n)3.81(3H, s)6.69(lH, d, J= 15.6Hz)7.17<1H,d,J= 15.6Hz)。 第4·郸櫧 合成甲基U)-6-乙基-4-氧基-2-辛烯酯·· ΠΙ-b。 第1步親合成3-(2-乙基丁基)-5-(甲氧基羧基)-2_異II惡 挫琳:8b。 (i)在氣氣流下,將399克<2.42其耳)卜溴-2-乙基丁 烷(化合物7b)在650 ml乾THF的溶液以2小時逐滴加入 61.7克(2. 54其耳)鎂在1升乾THF的懸浮液中,該反應是 維持在溫和的迴流下。在添加完成後*在攪拌1.5小時之 同時,讓該混合物回溫至室溫。用冰浴將該混合物冷卻.然 後將269|111(2.42莫耳)卜甲醯暇啶在45〇1«1乾^卩的溶液逐 滴加入該混合物中。在繼缳攪拌1小時後,加入300ml之 202克(2.9其耳)氫氯化羥基胺的水溶液,在攪拌1小時又 20分鐘之同時,讓該混合物回溫至室溫中。傾倒該反應混 合物,及用乙醚清洗殘餘物。合起來的有機層用水及鹽水 清洗,Μ無水硫酸鎂乾燥.及在真空中濃縮而得362克油狀 的圬粗產物。此不绖進一步純化及用於下一個反應。 (i i)在冰浴冷卻下,將362克之上所製得之粗肟在8 50 ml甲苯中的溶液逐滴加至2. 55升次氯睃納之10妬水溶液 ------------T —裝·------訂 (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83.3.10,000 at B7 經濟部中央標準扃員工消費合作社印製 五、發明説明() (约3_8其耳)及306*1 (3.39莫耳)丙烯甲酯及51mU363毫莫 耳)三乙基胺在850ml甲苯中之溶液之混合物中,及劇烈地 *拌。在添加完成後*在棟拌2小時之同時,讓該混合物 回溫至室溫中。在該反應混合物中加入冰水,及用乙酸乙 萃取。萃取物用水,硫代疏酸鈉的水溶液及鹽水清洗, 以無水碕酸鎂乾燥,及在真空中濃缩。在真空中蒸餾該殘 餘物而得255克油狀的所要的異噁唑啉(化合物8 )(自化合 物 7b為 49. 5%〉。沸點:130-13510 (5πππ Hg) 〇 ^-NHR: δ (CDC13)0.88(3H - t- J = 7.2Hz) 0.89 (3H > t» J= 7.2Hz) 1.27-1.61(5H,i)2.32(2H * d> J=7.0Hz) 3.2K2H* d* J= 9.0Hz)3. 79(3H ^ s)4.99(2H- J=9.0 Hz) 0 第2步驟合成化合物11 I -b號 該反應M類似於第3製備第2步驟的方法進行,自異 噁唑啉(化合物8 )開姶,而得所要的不飽和飼酯丨丨I-b。 沸點:85-90C (0.5mmHg)。 δ (CDC13)0.86(6H > t* J = 7.2Hz) 1 . 19-1.50(4H> i) 1.79-1.96 ( 1H,id)2.54(2H > d> J=6.6Hz) 3.82(3H- s)6.67(lH> d- J = 1 5 . 8Hz) 7 . 09 (1 H . d- J = 15.8Hz) 〇 竿5靱備 合成甲基(E)-5-乙基-4-氧基-2-戊烯酯:ΠΙ-c。 (請先閲讀背面之注意事項再填寫本頁)ΟΜ · OMe _ water squeezing solution NaOH; 6N HC1 M compound (III) can be prepared by any of the three methods provided below. Printed by the Central Standards Bureau of the Ministry of Economic Affairs, Shellfish Consumer Cooperatives, Cabinet (1 丨 1): > The first method, flute 3, to prepare synthetic methyl (E) -4-cyclohexyl ~ 4-oxo-2 -Butenyl ester: Diazepam synthesizes 3-Hexyl-5- (methoxycarbonyl) -2-isoxazoline: 8a. U) Under ice-cooling, a solution of 224 g (2.00 ears) of cyclohexanecarboxyaldehyde (compound 6a> in 133 ml of 99% ethanol) was added dropwise to 800 154 of 154 g (2.2 moles) of argon hydroxyl group Amine and 166 g of U. 20 acetic acid) potassium sulfonate in water. After the addition was completed, the mixture was allowed to warm to room temperature while stirring for 1 hour, and then extracted with 900 ml of ethyl acetate. The extract was washed with water and tritium water to obtain a solution of the desired oxime in ethyl acetate. (ii) Under ice-cooling, the oxime solution in ethyl acetate obtained above contained 200nl (2.40 ul) of methyl propylene methyl ester, and the solution was added dropwise to 3 liters of about 10% sodium hypooxygenate (about 4 bleach ) A mixture of an aqueous solution and 28 ι »1 (200 mils) of triethylamine, and violently! S mix for 2 hours. After the addition is complete, allow the mixture to warm to room temperature while searching for 1 hour, and then use ethyl acetate II ----- I-:-install ^ ------ order (please first W Read the notes on the back and fill in this page again.) This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) 83.3. 10,000 A7 B7 42〇66 1 ----- 5. Description of the invention () Ester extraction. The extract was washed with water and dried * with anhydrous magnesium thiosulfate * and concentrated in vacuo to obtain 369 g of a crude product of isoporphyrin (compound 8) (88% from compound 6a). * H-NMR: δ (CDCU) 1. 10-1. 45 (5Η-m) 1. 48-1. 90 (5H, m) 2_35-2.50 (lH, m) 3.19UH, d, J = 8.2Hz 3.20 (1H, d, J = 9.4Hz) 3.79 (3H, s) 4.96 (lH, dd, J = 8.2Hz, 94Hz). Flute 2 Synthetic Compound I II-a. (i> The crude product of the isoxazoline (compound 8a) (369 g) obtained above was dissolved in a mixture of 1.5 liters of methanol * 316 ml of water and 474 ml of acetic acid in the presence of 11.1 g of 10% rake-carbon and The mixture was stirred at room temperature under hydrogen for 6 hours. The palladium-carbon was removed by filtration, and the filtrate was concentrated in vacuo. Water was added to the residue, and the mixture was extracted with ethyl acetate. The extract was saturated with water * The sodium carbonate aqueous solution and brine were rinsed, dried over anhydrous magnesium sulfate, and dried in a vacuum to obtain 280 g of a crude product of the desired hydroxy ketone as an oil. (Ii > Under ice-cooling, 163 ml (2. 10 (Ear) Methanesulfonium M is added dropwise over a period of 1 hour to a solution of 280 g of the crude hydroxy ring and 8 19 mi (5.89 ears) of triethylamine in 1.4 liters of dry ethyl acetate. Stir for 1 hour At the same time, the mixture was allowed to warm to room temperature. After the addition of ice water *, concentrated hydrochloric acid acidified the hydrazone mixture * and extracted with ethyl acetate. The extract was washed with water, saturated aqueous sodium bisulfate solution and brine. , M dried over anhydrous magnesium acetate, and shrunk in vacuum. Remaining I. I ϋ r— I In I— * n. Nnnn In, 1T (please read the notes on the back before filling out this page) Printed on paper by the Central Bureau of Standards, Ministry of Economic Affairs, Shellfish Consumer Cooperative _National standard (€ yang) 6 4 grids (: 210/297 mm) 83.3.10,000 42066 1 Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, India and India A7 B7 _5. Description of the invention (), and 158 grams Crystals of fluorene esters that do not run (62% from compound 8a). Melt: 53-56 * 0. * H-NMR: δ (CDCU) 1.10-1.50 (5H.m) 1.60-2.00 < 5H, b) 2.50-2,63 (1H, n) 3.81 (3H, s) 6.69 (lH, d, J = 15.6Hz) 7.17 < 1H, d, J = 15.6Hz) Section 4. Synthesis of methyl groups U) -6-Ethyl-4-oxy-2-octenyl ester ...- II-b. In the first step, 3- (2-ethylbutyl) -5- (methoxycarboxy) -2-iso-II-oxaline was synthesized: 8b. (i) Under a gas flow, a solution of 399 g of < 2.42 its ears) bromo-2-ethylbutane (compound 7b) in 650 ml of dry THF was added dropwise to 61.7 g (2.54 its Ear) The suspension of magnesium in 1 liter of dry THF was maintained under gentle reflux. After the addition was complete * while stirring for 1.5 hours, the mixture was allowed to warm to room temperature. The mixture was cooled in an ice bath. Then a solution of 269 | 111 (2.42 moles) bupropion in 4501 «1 dry solution was added dropwise to the mixture. After stirring for 1 hour, 300 ml of an aqueous solution of 202 g (2.9 mils) of hydroxylamine hydrochloride was added, and the mixture was allowed to warm to room temperature while stirring for 1 hour and 20 minutes. The reaction mixture was decanted and the residue was washed with ether. The combined organic layers were washed with water and brine, dried over anhydrous magnesium sulfate, and concentrated in vacuo to obtain 362 g of an oily crude product. This was further purified and used in the next reaction. (ii) Under cooling in an ice bath, a solution of 362 g of the crude oxime prepared in 8 50 ml of toluene was added dropwise to 2.55 liters of hypochloroaline 10 aqueous solution-- ----- T —Package · ------ Order (please read the notes on the back before filling this page) This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 83.3.10,000 at B7 Printed by the Central Standard of the Ministry of Economic Affairs and printed by the Consumers' Cooperative. V. Description of the invention () (approximately 3_8 its ears) and 306 * 1 (3.39 moles) propylene methyl ester and 51mU363 millimoles) triethylamine in 850ml toluene In a mixture of solutions and stir vigorously *. After the addition is complete * while mixing for 2 hours, allow the mixture to warm to room temperature. Ice water was added to the reaction mixture, and extraction was performed with ethyl acetate. The extract was washed with water, an aqueous solution of sodium thiosodium and brine, dried over anhydrous magnesium acetate, and concentrated in vacuo. The residue was distilled in vacuo to obtain 255 g of the desired isoxazoline (compound 8) as an oil (49.5% from compound 7b). Boiling point: 130-13510 (5πππ Hg) 〇 ^ -NHR: δ (CDC13) 0.88 (3H-t- J = 7.2Hz) 0.89 (3H > t »J = 7.2Hz) 1.27-1.61 (5H, i) 2.32 (2H * d > J = 7.0Hz) 3.2K2H * d * J = 9.0 Hz) 3. 79 (3H ^ s) 4.99 (2H- J = 9.0 Hz) 0 Synthesis of compound 11 I-b in the second step. The reaction M is carried out similarly to the method in the third step and the second step. The oxazoline (compound 8) is opened to obtain the desired unsaturated feed ester Ib. Boiling point: 85-90C (0.5mmHg). δ (CDC13) 0.86 (6H > t * J = 7.2Hz) 1. 19-1.50 (4H > i) 1.79-1.96 (1H, id) 2.54 (2H > d > J = 6.6Hz) 3.82 (3H- s) 6.67 (lH> d- J = 1 5. 8 Hz) 7. 09 (1 H. d- J = 15.8 Hz) 〇5. Synthesis of methyl (E) -5-ethyl-4-oxy 2-pentenyl ester: III-c. (Please read the notes on the back before filling this page)
在T 訂 本紙乐尺度適用中國國家標準(CNS ) A4規格UI0X297公釐) 83.3*10,000 經濟部中央標準局貝工消費合作社印裝 42〇66 1 A7 — B7 五、發明説明() 良1步既-合成3-(卜乙基丙基)-5-(甲氧基羰基〉-2-異噁 睡啉:8c。 該反應以類似於第3製備第1步驟的方法進行,自(2 -乙基)丁基醛(化合物6c)開始而得所要的異咦唑啉(化合 物 8c>。沸酤:100-llOt: (2amHg) » ^-NMR: 6 (CDC13)0.88(3H,t. J = 7. 4Hz) 0.89 (3H > t> J= 7.4Hz)1.33-1.71(4H,b)2.36-2.53(1H . n)3.13 (1H> d> J= 9.6Hz)3.14(1H » d» J = 7.8Hz) 3.79 (3H > s) 4.99(1H,dd» J=9.6Hz,7.8Hz)。 第2步既合成彳h会物ΙΠ-co 該反應K類似於第3製備第2步驟的方法進行,自上 所製得的異噁唑啉(化合物8c),而得不飽和酮g| I Π -c。 沸點:68-72C (〇· 8mmHg)。 4H-NMR: <5 (CDCl3)0.86{6H,t,J= 7.4Hz) 1.42-1.80 (4Η,·)2.51-2.70(1Η - m)3.82(3H. s)6.72(lH- d. J = 15.8Hz)7. 19 (1H » d . J= 15. BHz) 〇 笛R斛備 合成甲基(E>-5-甲基-4-氧基-己烯酯:III-d 第1步皤合成5_(甲氧基羰基)-3-(1-甲基乙基)-2-異噁 唑啉:8d。 該反應Μ類似第3製備第1步驟的方法進行,自異丁 基醛(化合物6d)開始而得到所要的異噁唑啉(化合物8d)。 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐) -20 - 83.3.1〇〇〇〇 (請先閱讀背面之注11^項再填寫本頁) 訂 42066 1 A7 B7 五、發明説明( 沸點:84-88t (1 amHg)。 lH-NHR: δ (CDC13)1.19(6H,d,J= 7.0Ηζ)2.65-2.82 (lH,m>3_23(2H,d,J=9.4Hz>3.80(3H,s>4.99(lH,t 類,J=9.4Hz)。 隹2步黷化合物II I -d的合成 該反應是以類似第3製備第2步驟的方法進行*自上 所製得的異嵘唑啉(化合物8d開始,而得不飽和酮酯11 1 -<3 。沸點:76-80P (6nmHg)。^-NMR: 8 (CDC13) 1. 16(6H,d, J= 7.0Hz)2.76-2.94 (lH,m)3.82(3H » s)6.74(lH > d . J= 15. 8Hz) 7.20 (1H · d ,J= 15.8Hz>。 第3至第6製備之上述反應描述於下列之反應流程e 第1方法 1 ) Mg/THF; N — CHO; ^—^1· ^^^1 1^1 n n ]^i —xc· i 'M-^.^1 <請先閱讀背面之注意事項再填寫本頁) R1 -Br 7bi R1 = —CHjCHEtj 經濟部中央標率局負工消费合作社印製The paper scale of T-book is applicable to the Chinese National Standard (CNS) A4 specification UI0X297 mm) 83.3 * 10,000 Printed by the Bayer Consumer Cooperative of the Central Standards Bureau of the Ministry of Economics 42 066 1 A7 — B7 V. Description of the invention () Good 1 step -Synthesis of 3- (buethylpropyl) -5- (methoxycarbonyl> -2-isoxoroline: 8c. This reaction is carried out in a similar manner to the first step of the third preparation from (2-ethyl) Butylaldehyde (compound 6c) was started to obtain the desired isoxazoline (compound 8c>). Boiling point: 100-110: (2amHg) »^ -NMR: 6 (CDC13) 0.88 (3H, t. J = 7. 4Hz) 0.89 (3H > t > J = 7.4Hz) 1.33-1.71 (4H, b) 2.36-2.53 (1H. N) 3.13 (1H > d > J = 9.6Hz) 3.14 (1H »d» J = 7.8 Hz) 3.79 (3H > s) 4.99 (1H, dd »J = 9.6Hz, 7.8Hz). The second step is to synthesize 彳 h complex ΙΠ-co The reaction K is performed similarly to the method of the third step and the second step From the isoxazoline (compound 8c) prepared above, unsaturated ketone g | I Π-c is obtained. Boiling point: 68-72C (0.8 mmHg). 4H-NMR: < 5 (CDCl3) 0.86 (6H, t, J = 7.4Hz) 1.42-1.80 (4Η, ·) 2.51-2.70 (1Η-m) 3.82 (3H. S) 6.72 (lH- d. J = 15.8Hz) 7. 19 (1H »D. J = 15. BHz) 〇 Di Rho prepared synthetic methyl (E > -5-methyl-4-oxy-hexenyl ester: III-d Step 1 皤 Synthesis of 5_ (methoxycarbonyl) -3- (1-methylethyl) -2-isooxazoline: 8d. This reaction M is performed similarly to the method of the first step of the third preparation, starting from isobutylaldehyde (compound 6d) to obtain the desired iso Oxazoline (compound 8d). This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) -20-83.3.1 〇〇〇 (Please read Note 11 ^ on the back before filling this page) Order 42066 1 A7 B7 V. Description of the invention (Boiling point: 84-88t (1 amHg). LH-NHR: δ (CDC13) 1.19 (6H, d, J = 7.0Ηζ) 2.65-2.82 (lH, m > 3_23 (2H , D, J = 9.4Hz > 3.80 (3H, s > 4.99 (lH, t type, J = 9.4Hz).隹 Step 2 Synthesis of compound II I-d This reaction is carried out in a similar manner to Step 3 of Preparation 2 * from the isooxazoline prepared above (compound 8d, and the unsaturated keto ester 11 1- < 3. Boiling point: 76-80P (6nmHg). ^ -NMR: 8 (CDC13) 1. 16 (6H, d, J = 7.0Hz) 2.76-2.94 (lH, m) 3.82 (3H »s) 6.74 ( lH > d. J = 15. 8Hz) 7.20 (1H · d, J = 15.8Hz >. The above reactions prepared from 3 to 6 are described in the following reaction scheme e Method 1) Mg / THF; N — CHO; ^ — ^ 1 · ^^^ 1 1 ^ 1 nn] ^ i —xc · i 'M-^. ^ 1 < Please read the notes on the back before filling this page) R1 -Br 7bi R1 = — CHjCHEtj Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
R1 -CHO 水溶液HflN0H * HC1 2)水溶掖NaCIO Et3N/PhMe ^^002ΜθR1 -CHO aqueous solution HflN0H * HC1 2) Water soluble NaCIO Et3N / PhMe ^^ 002Mθ
1 ) η2νοη.ηο K2C〇3/水溶液 EtOH 2 )水溶液NaClO/EtOAc Et3N ^'COWe N-OΛΛ COgM 白 本紙張尺度適用中國國家榡準(CNS ) A4規格(210X297公釐) 83.3.1〇,〇〇〇 2066 1 A7 B7 五、發明説明( 6a; R1 = -〇 c; R1 = - CHEt2 d; R1 = - CHMe2 8a; R1 = -o b; R1 =-CH2CHEt2 c; R1 =-CHEt2 d; R1 = - CHMe21) η2νοη.ηο K2C〇3 / aqueous solution EtOH 2) Aqueous solution NaClO / EtOAc Et3N ^ 'COWe N-OΛΛ COgM White paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 83.3.1〇.〇 〇〇2066 1 A7 B7 V. Description of the invention (6a; R1 = -〇c; R1 =-CHEt2 d; R1 =-CHMe2 8a; R1 = -ob; R1 = -CH2CHEt2 c; R1 = -CHEt2 d; R1 = -CHMe2
1 )H2/Pd-C MeOH -,7f<^AcOH1) H2 / Pd-C MeOH-, 7f < ^ AcOH
2 ) MsCl I EtOAc Et3N2) MsCl I EtOAc Et3N
Me〇2〇 IH- a; Ft1Me〇2〇 IH- a; Ft1
(第3製備) b;R1=-CH2CHEt2 (第 4 製備) c; R1 = - CHEt2 d; R1 =-CHMe2 (第5製備) (第6製備) 齟備彳卜.会物(ΤΠ)的笛2方法 (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局負工消費合作社印製 合成甲基(Ε)-4-環己基-4-氧基-2-丁烯酯:Πϊ-a。 第L步驟合成(± )-3-乙烯氧基-3-(甲氧基欺基)丙酸 :10 « 將201克(1.50莫耳)DL-羥基丁二酸(化合物9 >及750 ml乙醯氯的混合物在室溫中擻拌68小時,及在再攪拌 2小時。該反應溶液在真空中濃编,及將300nl的甲笨加 到所產生的殘餘物。該混合物在真空中再度濃缩,然後將 該殘餘再度進行添加一猥縮操作一次。所產生的酸酐自 本紙張尺度適用中國固家樣準(CNS ) A4現格(210X297公釐) 83.3.10,000(3rd preparation) b; R1 = -CH2CHEt2 (4th preparation) c; R1 =-CHEt2 d; R1 = -CHMe2 (5th preparation) (6th preparation) 2 method (please read the notes on the back before filling this page) Order the synthetic methyl (E) -4-cyclohexyl-4-oxy-2-butenyl ester printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs: Πϊ-a. Step L: Synthesis of (±) -3-vinyloxy-3- (methoxymethoxy) propionic acid: 10 «201 g (1.50 moles) of DL-hydroxysuccinic acid (Compound 9 >) and 750 ml The mixture of acetochloro chloride was stirred at room temperature for 68 hours, and stirred for another 2 hours. The reaction solution was concentrated in vacuo, and 300 nl of methylbenzyl was added to the resulting residue. The mixture was again in vacuum Concentrate, and then add the residue again for a curling operation. The acid anhydride produced is from China Paper Standard (CNS) A4 (210X297 mm) 83.3.10,000
42066 I 經濟部中央標準局貝工消费合作社印製 A7 B7 _五、發明説明() 100·1甲笨結晶化。在真空中蒸發甲苯而得之结晶殘餘物 中,在冰浴的冷卻下加入1.5升的甲醇。將混合物在室溫 中堍拌1小時,然後靜置15小時。在真空中澴缩後,在該 殘餘物上加入300ml的甲苯,在真空中再度濃编該混合物 。該殘餘物自150·1的甲苯中結晶,而該晶體用石油醚清 洗而得到279克(98% )的所要的狻酸(化合物1〇)之晶體。 熔點:〜63Τ:。 ^-NMR: δ (CDC1,)2. 16(BH,s)2.96(2H,d ^ J=6.0 Hz)3.78(3H * s)5.49UH,t,J = 6.0Hz)。 合成化合物IΙΪ-a。 (i) 將196克(1.10其耳)上所製得的羧酸(化合物10)及 196ml (1.65冥耳)亞硫醯氣的混合物在30C攪拌30分鐘* 及在50C再擬拌1小時。在真空中濃縮該反應溶液 > 及将 250ml甲苯加至所產生的殘餘物上。在真空中再度濃縮該 混合物,然後將該殘餘物再度進行添加一濃缩操作,而產 生所要的酸氯化物。此不經進一步純化即用於下一傾反應 a (ii) 在氮氣流下*將1.17升(1.19冥耳)1.02 Μ溴化環 己基鎂在THF中的溶液在25¾ Μ 2.5小時的時間逐滴加入 上述所裂得的粗酸氣化物及9.52克(5.00毫莫耳)碘化亞銅 在1升乾THF中之懸浮液。在添加完成後,將該混合物再 抿拌30分鐘,及藉由添加1升的1·3 Ν氫氣酸及冰而將反 應驟冷。用乙酸乙酯萃取該反應溶液,該萃取物甩鹽水, (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家棣準(CNS ) Α4規格(210Χ:ί97公釐} 83.3.10,000 42066 1 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明() 飽和的重硝睃納水溶液,碕代确酸納水溶液及鹽水淸洗》 及用無水磙酸鎂乾燥。在真空中溫缩該溶液而得所要酮類 的粗產物。此不經進一步纯化邸用於下—値反應。 (iii)在上所製得的粗醑在550ml乾乙腈的溶液中,加 入230b1(1.65莫耳)的三乙基胺,該混合物在回流下加熱 1小時。在冰浴冷卻下,將1升的1.3 N氫氣酸加到該反 睡溶液中,及用乙酸乙酯萃取該混合物。該萃取物Μ鹽水 清洗,及Κ無水硫酸鎂乾燥。在真空下澴缩之後,藉由添 加1升的石油醚而將該殘餘物結晶化。該結晶自85%甲醇 水溶液中再度结晶而得76.8克所要的不飽和阑酯11 I -a的 結晶。更進一步,結合結晶及再結晶的母液及在真空中蒸 餾,然後將該蒸餾液自85%甲醇水溶液中再結晶,而得另 外的32.5克所要的化合物。總產量:109克(自化合物10為 51% )。瑢酤:56-57Ό。 此化合物之1H-NMR光譜和第3製備所得者一致。 笛ft剪碓 合成甲基<E)-6-乙基-4-氧基〜2-辛烯酯:IU-b。 該反應以類似於第7製備第2步驟的方法進行,自化 合物10 (第7製備第1步驟)及溴化(2-乙基)丁基鎂開姶, 而得所要的不飽和酮S旨II bb。所產生化合物的物理性質 和第4製備所得化合物完全一致。 第.3_製.備. 合成甲基(E>-5_乙基-4-氣基-2-戊烯醋:ΙΠ-c。 該反應以類似第7裂備第2步费的方法進行,自化合 {請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS) A4規格(210><297公釐) 83. 3*10,000 42066 A7 B7 五、發明説明‘( 合物1〇(第7製備第1步魅)及溴化(2-乙基)丁基鎂開姶* 而得所要的不飽和_酯111-1)。所產生化合物的物理性質 和第4製備所得化合物完全一致。 隹9剪備 合成甲基(E)-5-乙基-4-氧基-2-戊烯酯:III-c。 該反應以類似於第7製備第2步驟的方法進行,自化 合物10 (第7裂備第1步驟)及溴化Π-乙基)丙基鎂開始* 而得所要的不飽和酮g|in-c。該所產生的化合物之物理 特性和第5製備所得之化合物完全相同。 笙10靱備 合成甲基(E卜4-氧基-2-己烯酯:Π I-e。 該反應以類似於第7製備第2步驟的方法進行,自化 合物1〇(第7製備第1步驟)及溴化乙基鎂開始,而得所要 的不飽和醑酯Πί-e。 沸點:87-90TC (8 nmHg〉。 ^-NMR: δ (CDC13) 1. 14 (3Η, t - J = 7.2Hz) 2.67 { 2H , q- J= 7.2Hz)3.81(3H . s)6.69(lH» d> J= 16.0Hz)7.09 (1H . d . J= 16.0Hz) 〇 (請先閎讀背面之注意事項再填寫本頁) 經濟部4-央標準局員工消費合作社印製 上述第7至第10製備的反應描逑於下列反應流程。 第2方法 HO ho2c¥ ,co2h42066 I Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 _V. Description of the invention () 100 · 1 Jiaben crystallized. To a crystalline residue obtained by evaporating toluene in a vacuum, 1.5 liters of methanol was added under cooling in an ice bath. The mixture was stirred at room temperature for 1 hour, and then left to stand for 15 hours. After being condensed in vacuum, 300 ml of toluene was added to the residue, and the mixture was concentrated again in vacuo. The residue was crystallized from 150 · 1 of toluene, and the crystals were washed with petroleum ether to obtain 279 g (98%) of the desired osmic acid (compound 10) as crystals. Melting point: ~ 63Τ :. ^ -NMR: δ (CDC1,) 2. 16 (BH, s) 2.96 (2H, d ^ J = 6.0 Hz) 3.78 (3H * s) 5.49 UH, t, J = 6.0 Hz). Synthesis of compound III-a. (i) A mixture of the carboxylic acid (compound 10) prepared on 196 grams (1.10 ears) and 196 ml (1.65 mole) of thionine was stirred at 30C for 30 minutes * and at 50C for another 1 hour. The reaction solution was concentrated in vacuo > and 250 ml of toluene was added to the resulting residue. The mixture was concentrated again in vacuo, and the residue was subjected to an addition and concentration operation again to produce the desired acid chloride. This was used in the next reaction without further purificationa (ii) Under a nitrogen stream * 1.17 liters (1.19 morin) of a solution of 1.02 M cyclohexylmagnesium bromide in THF was added dropwise over a period of 25 ¾ 2.5 hours A suspension of the crude acid gaseous product obtained above and 9.52 g (5.00 mmol) of cuprous iodide in 1 liter of dry THF. After the addition was complete, the mixture was stirred for another 30 minutes, and the reaction was quenched by adding 1 liter of 1.3 N hydrogen acid and ice. The reaction solution was extracted with ethyl acetate, and the extract was shaken with brine. (Please read the precautions on the back before filling out this page.) This paper size applies to China National Standards (CNS) A4 (210 ×: 97mm) 83.3. 10,000 42066 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention () Saturated dinitrate sodium hydroxide solution, sodium hydroxide solution and brine washing and drying with anhydrous magnesium acetate. Under vacuum Shrink the solution at medium temperature to obtain the crude product of the desired ketones. This was used in the next-fluorene reaction without further purification. (Iii) To the solution of the crude fluorene prepared in 550 ml of dry acetonitrile, 230b1 (1.65 Mol) triethylamine, the mixture was heated under reflux for 1 hour. Under ice-cooling, 1 liter of 1.3 N hydrogen acid was added to the anti-sleep solution, and the mixture was extracted with ethyl acetate. The The extract was washed with brine and dried over anhydrous magnesium sulfate. After being condensed under vacuum, the residue was crystallized by adding 1 liter of petroleum ether. The crystal was recrystallized from an 85% methanol aqueous solution to obtain 76.8 g. Desaturated diaphragm Crystallization of 11 I -a. Furthermore, the mother liquor of crystallization and recrystallization was combined with distillation in vacuum, and then the distillation solution was recrystallized from an 85% methanol aqueous solution to obtain another 32.5 g of the desired compound. Total yield: 109 g (51% from compound 10). 瑢 酤: 56-57 Ό. The 1H-NMR spectrum of this compound is the same as that obtained in the third preparation. Fut ft cut to synthesize methyl < E) -6-ethyl- 4-oxy ~ 2-octenyl ester: IU-b. This reaction is carried out in a similar manner to the second step of the seventh preparation. The compound 10 (the first step of the seventh preparation) and the (2-ethyl) butylmagnesium bromide are opened to obtain the desired unsaturated ketone S. II bb. The physical properties of the compound produced were completely consistent with those obtained in the fourth preparation. Section 3. Preparation. Preparation. Synthesis of methyl (E > -5_ethyl-4-amino-2-pentenate: ΙΠ-c. The reaction is performed in a manner similar to Step 2 of Step 7 Self-combination {Please read the precautions on the back before filling this page) This paper size is applicable to Chinese National Standard (CNS) A4 (210 > < 297 mm) 83. 3 * 10,000 42066 A7 B7 V. Description of the invention '(Compound 10 (Step 7 in the first step of the preparation) and (2-ethyl) butylmagnesium bromide are opened to give the desired unsaturated ester 111-1). The physical properties of the compound produced were completely consistent with those obtained in the fourth preparation.隹 9 Trimming Synthesis of methyl (E) -5-ethyl-4-oxy-2-pentenyl ester: III-c. This reaction is carried out in a similar manner to the second step of the seventh preparation, starting from compound 10 (the first step of the seventh cracking preparation) and magnesium bromide Π-ethyl) propyl * to obtain the desired unsaturated ketone g | in -c. The physical properties of the produced compound were identical to those of the compound prepared in the fifth step. Sheng 10 prepared a methyl (4-oxo-2-hexenyl ester: Π Ie. This reaction was performed in a similar manner to the second step of the seventh preparation, from compound 10 (the first step of the seventh preparation). ) And ethyl magnesium bromide to obtain the desired unsaturated fluorene ester Πί-e. Boiling point: 87-90TC (8 nmHg>). ^ -NMR: δ (CDC13) 1. 14 (3Η, t-J = 7.2 Hz) 2.67 {2H, q- J = 7.2Hz) 3.81 (3H. S) 6.69 (lH »d > J = 16.0Hz) 7.09 (1H. D. J = 16.0Hz) 〇 (Please read the note on the back first Please fill in this page for further details.) The reactions prepared by the Consumer Cooperatives of the 4-Central Standards Bureau of the Ministry of Economic Affairs printed the above 7 to 10 are described in the following reaction flow. Method 2 HO ho2c ¥, co2h
)AcCI) AcCI
AcOAcO
2 ) MeOH2) MeOH
Me〇2〇Me〇2〇
,C02H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83.3.10,000 ^2066 ] A7 B7 五、發明説明(), C02H This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 83.3.10,000 ^ 2066] A7 B7 V. Description of the invention ()
1 ) soci2----- 2) R1~Mg日r/THF Cul ( cat.) 3 ) Et3N / MeCN1) soci2 ----- 2) R1 ~ Mg r / THF Cul (cat.) 3) Et3N / MeCN
III- a; b; R —^ ^ (第7製備)R1 =-CH2CHB2 (第 8 製備) C;R1 =-CHEt2 (第9製備) e; R1 = - Et (第10製備) i諳先間讀背面之注意事項再填寫本頁〕 經濟部中央標準局員工消費合作社印裝III- a; b; R — ^ ^ (Preparation 7) R1 = -CH2CHB2 (Preparation 8) C; R1 = -CHEt2 (Preparation 9) e; R1 =-Et (Preparation 10) i 谙 前 间Read the notes on the back and fill out this page] Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs
餺確化会物(TTT):>^3方法 策靱備 合成甲基(E)-6-乙基-4-氧基-2-辛烯酯:l〗I-b。 第1击既合成(E)-3_(甲氧羰基)丙烯醛氣:12 <i)在300克(3.06莫耳)順式丁烯二酸酐在900ml乾甲 苯之懸浮液中加入136ml (3.37其耳)甲烷及3.0ml的亞碕醢 氣,該混合物在回流下加熱2小時冰浴冷郤該反應溶 液,收集沈澱的结晶而得所要化合物之粗结晶。該結晶自 THF (500sil)-異丙基醚(1升)中再結晶,而得210克(52,7 %)所要的單一甲基醋。熔點:145-146^。 (U)在97. 5克(750毫莫耳)之上所裂得的甲基酯在250 ml乾苯中的憨浮液中,加入82.2sil(l.13其耳)亞硫醯氯及 l.CllBlDMF,在70ΊC攪拌該混合物2.5小時。在真空中濃缩 及蒸餾該反醮混合物,而得95.3克(85.3%)油狀的所要的 睃氣化物(化合物12)。沸點:72-731 (15aiHg>。 HMR: S (CDC13)3.86<3H,s)6.99(1H,AB 類型,J 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83,3. !〇,〇〇〇 e〇e6 丨 A7 B7 _ 五、發明説明() =15_4Hz>7.00 (1H,AB類型,J = 15.4Hz)。 第2步驟 合成化合物III-b。 在氣氣滾下,將728·1 (837毫其耳)1.15 Μ氣化鋅在 ΤΗΡ中的溶液,Μ55分鐘的時間在冰浴冷卻下逐滴加至 0,97 Μ溴化(2-乙基)丁基鎂(860ml ; 837毫莫耳)的THF溶 液。在添加完成後,將該混合物纽續攪拌50分鐘,及加入 14 S克<12.8毫莫耳)四(三苯基膦)一鈀。接箸,以1.5小 時的時間逐滴加人95.3克(639毫莫耳)上所製得的酸氣化 物(化合物12)在25〇nl乾THF中的溶液。在添加完成後, 雄绪攙拌該混合物30分_,加入600»1 3N氫氯酸,及用乙 酸乙酯萃取該混合物。該萃取物用水及鹽水清洗,及Μ無 水硫酸鎂乾燥。在真空中濃縮之後,該殘餘物溶於200ml 乙醚及η-己烷(1: 4)的混合物中,及過濾通過矽膠墊(300 克>。Ml升上逑之相同混合溶劑沖洗該矽膠。將濾液及 沖洗液結合*然後在真空中濃縮該混合物。在真空中蒸館 該殘餘物而得67.6克(53.4¾)油狀的所要之不飽和闺酯 111-b 〇 經濟部中央標準局貝工消費合作社印象 所產生化合物之物理性質和第4製備所得之化合物完 全一致。 上述第11製備的反應描述於下列之反應流程。 83.3. 10,000 (請先閎讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX”7公釐) 420661 A7 B7 五、發明説明() )MeOH/PhMe S〇aa {cat) » 2>SOCVPhH Μβ〇2〇 第3方法(TTT): > ^ 3 Method Policy Preparation Synthesis of methyl (E) -6-ethyl-4-oxy-2-octenyl ester: l I-b. The first hit was to synthesize (E) -3_ (methoxycarbonyl) acrolein gas: 12 < i) To a suspension of 300 g (3.06 moles) of cis-butenedioic anhydride in 900 ml of dry toluene was added 136 ml (3.37 (Ear) methane and 3.0 ml of thorium gas, the mixture was heated under reflux for 2 hours to cool the reaction solution in an ice bath, and the precipitated crystals were collected to obtain crude crystals of the desired compound. This crystal was recrystallized from THF (500sil) -isopropyl ether (1 liter) to obtain 210 g (52,7%) of the desired single methyl vinegar. Melting point: 145-146 ^. (U) In a mash float of methyl ester obtained in 97.5 g (750 millimoles) in 250 ml of dry benzene, 82.2sil (1.13 of its ears) thionyl chloride and l. CllBlDMF, the mixture was stirred at 70 ° C for 2.5 hours. The reaction mixture was concentrated and distilled in vacuo to obtain 95.3 g (85.3%) of the desired hydrazone gaseous compound (Compound 12). Boiling point: 72-731 (15aiHg >. HMR: S (CDC13) 3.86 < 3H, s) 6.99 (1H, AB type, J This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) 83, 3.! 〇, 〇〇〇〇e〇e6 丨 A7 B7 _ V. Description of the invention () = 15_4Hz> 7.00 (1H, AB type, J = 15.4Hz). The second step synthesizes compound III-b. Next, a solution of 728.1 (837 milli-kilars) 1.15M zinc vaporized in TP was added dropwise to 0,97M bromide (2-ethyl) butyl bromide under ice-cooling for a period of 55 minutes. A solution of magnesium (860 ml; 837 mmol) in THF. After the addition was complete, the mixture was stirred for 50 minutes, and 14 S g < 12.8 mmol) of tetrakis (triphenylphosphine) -palladium was added. Then, a solution of 95.3 g (639 mmol) of the acid gaseous compound (Compound 12) prepared in 25.0 nl of dry THF was added dropwise over a period of 1.5 hours. After the addition was completed, the mixture was stirred for 30 minutes, 600 »1 3N hydrochloric acid was added, and the mixture was extracted with ethyl acetate. The extract was washed with water and brine, and dried over anhydrous magnesium sulfate. After concentration in vacuo, the residue was dissolved in 200 ml of a mixture of diethyl ether and η-hexane (1: 4), and filtered through a silicone pad (300 g). Ml of the same mixed solvent on top was rinsed. The filtrate and rinse were combined * and the mixture was concentrated in vacuo. The residue was evaporated in vacuo to give 67.6 g (53.4¾) of the desired unsaturated ester 111-b in the form of an oil. Central Bureau of Standards, Ministry of Economic Affairs The physical properties of the compounds produced by the industrial and commercial cooperative impressions are exactly the same as those obtained in the fourth preparation. The reaction of the above eleven preparation is described in the following reaction scheme. 83.3. 10,000 (Please read the precautions on the back before filling this page) This paper size applies the Chinese National Standard (CNS) A4 specification (2 丨 OX "7mm) 420661 A7 B7 V. Description of the invention ()) MeOH / PhMe S〇aa {cat)» 2 > SOCVPhH Μβ〇2〇3 method
12 1112 11
R1 -MgBr/THF ZnC!2 [Ph3P ]4Pd (cat.) Me〇aCR1 -MgBr / THF ZnC! 2 [Ph3P] 4Pd (cat.) Me〇aC
lll-b; R1 = -CH2CHEt2 經濟部中央標準局男工消費合作社印製 製備化合物(I)的實例提供於下。 谊1例 合成3(-環己烷羰基)-卜(3, 4-二甲氧基苯基)-4-羥 S-2-(甲氧基羰基)-6,7,8-三甲氧基萘:I-la。 第_1步驟...合成3-(環己烷羰基卜卜(3,4-二甲氧基苯基> -1,2-二氫-1,4-二羥基-2-(甲氧基羰基)-6,7 > 8-三甲 氧基萘:IV-la。 在気氣流下,在冰浴冷卻下將1.64Mn-丁基娌在η-己 烷(700ml ; 1.1 5其耳)的溶液逐滴加入到256m丨(1.15毫冥 耳)(TMS)eNH在1.15升乾THF中的溶液。207克(575毫其 耳)內酯Π-1(第1製備)在1.15升乾DMF中的瑢液,Μ 1小 時的時間逐滴加到Μ乾的冰_丙酮冷卻的該反應溶液中。 在ϋ續搜拌該混合物45分鐘後,134克(684毫其耳)不飽和 飼酯ΙΠ-a(第3製備)在456al乾THF的溶液Μ4 5分鐘的時 間逐滴加入。在添加完成後*搜拌該混合物15分鑊,讓其 回溫至0 Ό ·及在相同的溫度攪拌3小時。在反睡溶液中 加人1.8升2N氫氯酸,及用乙酸乙酯萃取該混合物。萃取 ^^^1- —^n in it n (,請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83.110,000 420661 A7 B7 經濟部令央標隼局員工消费合作社印製 五、發明説明() 物用水及0[水清洗,Μ無水硫睃鎂乾燥,及在真空中澴縮 。自1升的甲醇结晶該殘餘物而得180克所要化合物IV-la 的粗结晶。然後,將再結晶作用之母液濃縮*及再結晶化 該殘餘物二·次而得另外7.0克的化合物IV-la。缠產量: 155克(自化合物II-1為49% )。 熔點:154-155C。 ^-NMR: δ (CDC1 3)0.90-1.83 (10H,m) 2.40-2.58 (1Η ,n)3.45(3H, s)3.67(3H, s>3.82(3H, s)3.85(3H, s) 3.93(1H, s)3.94(3H, s〉3.99(3H, s>5.57<lH, s>6.42 (1H,dd,J=8.4Hz,2.4Hz)6.64(lH,d> J=8,4Hz>7.14 <1H,d,J= 2.4Hz〉7.51(lH,s)。 第2步黯合成化合物I-U。 在氣氣流下,44.8ml (364毫莫耳)BF3 · 0EU在90nl乾 二氯甲烷的溶液,以30分鐘的時間在冰浴冷卻下加到155 克(279毫冥耳 >上逑所得之化.合物IV-la在750ml乾二氯甲 烷的溶液,在相同的溫度逛續攪拌50分鐘。在該反應溶液 中加人58.4ml(420毫冥耳)三乙基胺,及在室溫中攪抹該 混合物30分鐘。在真空中濃縮之後*將水加到殘餘物上, 用乙酸乙酯萃取該混合物。該萃取物用1N氫氯酸*水及鹽 水清洗,以無水硫酸鎂乾燥。在真空中濃縮後,該殘餘物 自500B1甲醇中结晶,該結晶自二氣甲烷一甲醇再結晶二 次,而得140克(93%)所要之化合物I-la。 熔點:150-151Ϊ:。 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家揉準(CNS ) A4^格(210X297公釐) 83. 3.10,000 420661 經濟部中央標準局員工消費合作社印裝 A7 B7五、發明説明() ^-NMR: δ (CDC13)1.15-1.90(l〇H,m) 2.70-2.90 (1Η -m)3.24(3H> s)3.44(3H» s)3.86(3H> s)3.89(3H· s) 3.93C3H. s)4.03(3H^ s)6.8 1-6.87(3H » m)7.71(lH> s) 13.99(1H , s)。 1R ; υ {Nujol)1714> 1606- 1580» 1516* 1489» 1410* 1240,1197,1142,1107,1063,1027,1004 公分-1。 C3nH34〇3之分析計算得:C66.90%,H6.36%, 發現:C66.92%,H6.39%。 第2俐 合成卜(3,4-二甲氧基苯基)-3-(3-乙基-卜氧戊基)_ 4-羥基-2-(甲氧基羰基)_6,7,8-三甲氧基_ : I-lb? 第1步賺合成卜(3,4-二甲氧基苯基)-3-(3-乙基-卜氧 戊基)-1,2-二氫-1,4-二羥基_2-(甲氧基Μ基)-6,7,8 -三甲氧基萘:IV-lb。 在気氣滾下,180克(0.05其耳)内酯11-1(第1製備) 在500ml乾二氯甲烷的溶液在-781: Μ 1小時的時間逐滴加 到 1 升 1.0 M LiN(TMS)2-THF溶液(1.0莫耳 * 2.0當量)。 在繼績搜拌該混合物40分鐘後,將109克(0.55莫耳,i. 1 當量)不飽和嗣酯ΠΙ-b(第4製備)在30 0ml乾THF的溶液 Μ 40分鐘的時間逐滴加入。在添加完成後,讓該混合物回 溫至0 ΐ *及在冰浴冷卻下攪拌3小時。在該反應溶液中 Φ 加入1升2Ν氫氣酸及冰,及以乙酸乙酯萃取該混合物。該 萃取物用水及發水清洗*以無水硫酸鎂乾燥,及在真空中 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度通用中國國家標準(CNS ) Α4規格(210X297公釐) 83.3.10,000 420661 經濟部中央標準局員工消費合作社印裝 A7 B7五、發明説明() 濃缩。該殘餘物自700al甲醇结晶而得到晶體。該結晶進 一步自600ml甲醇中再结晶化二次,而得194克(7〇%)所要 的化合物IV-lb。 熔點:132-133^。 *H-NMR: δ (CDC1a)0.65 (ΒΗ - t> J= 7.2Hz)0.69 (3Η » t. J= 7.2Hz) 0.80-1. 29 (5H . m)2.〇3(lH> dd » J=14.0 Hz, 7.0 Hz)2.31(lH, dd, J=14.〇Hz, 6.4Hz)3.40(3H, s)3.67(3H* s)3.81{3H. s)3.86(3H. s)3.88(lH> s)3.94 (3H » s)3.99(3H* s)5.73(lH» s)6.43(lH. dd . J=8.4Hz -2.2Hz)6.64(lH ^ d ^ J = 8.4Hz) 7 . 14 (1H » d· J=2.2Hz) 7.54(1H , s)。 m P. 合成化合物卜1 b。 該反應M類似第1例第2步驟的方法進行,自上所製 得的化合物IV-lb開始而得所要的化合物I-lb。 熔點:128· 5-129.5C (二氣甲烷〜甲醇)。 LR: d (CDC13)0.83(6H, t, J=7 Hz)1.20-1.42 (4H » m) 1 . 96-2. 12 (1H - m)2.73(2H* d · J=6 Hz)3.25(3H ,s)3.44(3H,s)3.86(3H.s)3.89(3H,s)3.93(3H.s)4.04 (3H,s)6.78-6.90(3H,ra)7.73(lH,s)14.38(lH,s)。 1R; υ (CHC13)2968, 1729, 1606, 1576, 1514, 1489, 1464,1412,1139,1064,1028 公分-1° C3〇H3S〇9 之計算分忻:C66.65%,H6.71% ; 發現:C66.72%,H6. 69%。 ί·ί— - If----------- 丁 s ^-5 (請先閱讀背面之注意事項再填寫'本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83.3.10,000 42066 1 A7 ____B7_ 五、發明説明() 第3例lll-b; R1 = -CH2CHEt2 Printed by the Male Workers Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs An example of the preparation of compound (I) is provided below. Example 1 Synthesis of 3 (-Cyclohexanecarbonyl) -Bu (3,4-dimethoxyphenyl) -4-hydroxyS-2- (methoxycarbonyl) -6,7,8-trimethoxy Naphthalene: I-la. Step _1 ... Synthesis of 3- (Cyclohexanecarbonylb (3,4-dimethoxyphenyl) > 1,2-dihydro-1,4-dihydroxy-2- (methoxy Carbonyl) -6,7 > 8-trimethoxynaphthalene: IV-la. 1.64Mn-butylpyrene in η-hexane (700ml; 1.1 5 acetic acid) under thallium gas flow under cooling in an ice bath. The solution was added dropwise to a solution of 256 m (1.15 mmol) (TMS) eNH in 1.15 liters of dry THF. 207 g (575 mils) of lactone Π-1 (preparation 1) in 1.15 liters of dry DMF The mash solution in M was added dropwise to the reaction solution cooled by M with ice and acetone over a period of 1 hour. After the mixture was continuously stirred for 45 minutes, 134 g (684 mil) of unsaturated forage ester ΙΠ-a (Preparation 3) was added dropwise over a period of 5 minutes in a solution of 456al of dry THF solution M4. After the addition was completed, * the mixture was stirred for 15 minutes and allowed to warm to 0 ° C. And stirred at the same temperature 3 hours. Add 1.8 liters of 2N hydrochloric acid to the anti-sleep solution and extract the mixture with ethyl acetate. Extract ^^^ 1- — ^ n in it n (, please read the precautions on the back before filling in this Page) The size of the paper used in the edition is subject to the Chinese National Standard (CNS) A 4 Specifications (210X297 mm) 83.110,000 420661 A7 B7 Printed by the Ministry of Economic Affairs, Central Standards Bureau, Employee Consumer Cooperatives. V. Description of the invention () Material water and 0 [Water cleaning, anhydrous magnesium sulfate drying, and in vacuum Shrinking. Crystallizing the residue from 1 liter of methanol to obtain 180 g of crude crystals of the desired compound IV-la. Then, the mother liquor of recrystallization was concentrated * and the residue was recrystallized twice to obtain another 7.0 g Compound IV-la. Yield: 155 g (49% from compound II-1). Melting point: 154-155C. ^ -NMR: δ (CDC1 3) 0.90-1.83 (10H, m) 2.40-2.58 (1Η , N) 3.45 (3H, s) 3.67 (3H, s > 3.82 (3H, s) 3.85 (3H, s) 3.93 (1H, s) 3.94 (3H, s> 3.99 (3H, s > 5.57 < lH, s &6.4; (1H, dd, J = 8.4Hz, 2.4Hz) 6.64 (lH, d > J = 8,4Hz > 7.14 < 1H, d, J = 2.4Hz> 7.51 (lH, s). Step 2 A synthetic compound IU was added. Under an air current, 44.8 ml (364 mmol) of BF3 · 0EU in 90 nl of dry dichloromethane was added to 155 g (279 mmol) in an ice bath for 30 minutes. ; The obtained compound was obtained. Compound IV-la in 750 ml of dry dichloromethane Solution, stirring was continued visiting at the same temperature for 50 minutes. To the reaction solution was added 58.4 ml (420 milliliters) of triethylamine, and the mixture was stirred at room temperature for 30 minutes. After concentration in vacuo * water was added to the residue and the mixture was extracted with ethyl acetate. The extract was washed with 1N hydrochloric acid * water and brine, and dried over anhydrous magnesium sulfate. After concentration in vacuo, the residue was crystallized from 500B1 methanol, and the crystals were recrystallized twice from methane-methanol to give 140 g (93%) of the desired compound I-la. Melting point: 150-151Ϊ :. (Please read the notes on the back before filling this page) This paper size is applicable to China National Standards (CNS) A4 ^ (210X297 mm) 83. 3.10,000 420661 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention () ^ -NMR: δ (CDC13) 1.15-1.90 (lOH, m) 2.70-2.90 (1Η -m) 3.24 (3H > s) 3.44 (3H »s) 3.86 (3H > s) 3.89 (3H · s) 3.93C3H. S) 4.03 (3H ^ s) 6.8 1-6.87 (3H »m) 7.71 (lH > s) 13.99 (1H, s). 1R; υ {Nujol) 1714 > 1606- 1580 »1516 * 1489» 1410 * 1240, 1197, 1142, 1107, 1063, 1027, 1004 cm-1. Analysis of C3nH34〇3 calculated: C66.90%, H6.36%, found: C66.92%, H6.39%. 2nd synthesis of (3,4-dimethoxyphenyl) -3- (3-ethyl-boxypentyl) _ 4-hydroxy-2- (methoxycarbonyl) _6,7,8- Trimethoxy_: I-lb? The first step is to synthesize (3,4-dimethoxyphenyl) -3- (3-ethyl-oxopentyl) -1,2-dihydro-1 , 4-Dihydroxy_2- (methoxymethoxy) -6,7,8-trimethoxynaphthalene: IV-lb. Under a thoron roll, a solution of 180 g (0.05 ul) of lactone 11-1 (first preparation) in 500 ml of dry dichloromethane was added dropwise to 1 liter of 1.0 M LiN at -781 over a period of 1 hour. TMS) 2-THF solution (1.0 mole * 2.0 equivalents). After the mixture was stirred for 40 minutes, a solution of 109 g (0.55 mol, i. 1 equivalent) of unsaturated ethyl ester III-b (Production 4) in 300 ml of dry THF was dripped over 40 minutes. Join. After the addition was complete, the mixture was allowed to warm to 0 ° F. * and stirred for 3 hours under cooling in an ice bath. To the reaction solution was added 1 liter of 2N hydrogen acid and ice, and the mixture was extracted with ethyl acetate. The extract was washed with water and hair * Dried with anhydrous magnesium sulfate, and in a vacuum (please read the precautions on the back before filling this page) The paper size is in accordance with the Chinese National Standard (CNS) Α4 specification (210X297 mm) 83.3 .10,000 420661 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention () Condensed. The residue was crystallized from 700 al of methanol to obtain crystals. This crystal was further recrystallized twice from 600 ml of methanol to obtain 194 g (70%) of the desired compound IV-lb. Melting point: 132-133 ^. * H-NMR: δ (CDC1a) 0.65 (ΒΗ-t > J = 7.2Hz) 0.69 (3Η »t. J = 7.2Hz) 0.80-1. 29 (5H. M) 2.〇3 (lH > dd» J = 14.0 Hz, 7.0 Hz) 2.31 (lH, dd, J = 14.0Hz, 6.4Hz) 3.40 (3H, s) 3.67 (3H * s) 3.81 (3H. S) 3.86 (3H. S) 3.88 ( lH > s) 3.94 (3H »s) 3.99 (3H * s) 5.73 (lH» s) 6.43 (lH. dd. J = 8.4Hz -2.2Hz) 6.64 (lH ^ d ^ J = 8.4Hz) 7. 14 (1H »d · J = 2.2Hz) 7.54 (1H, s). m P. Synthetic compound BU 1 b. This reaction M is carried out in a similar manner to the second step of the first example, and the desired compound I-lb is obtained starting from the compound IV-lb prepared above. Melting point: 128 · 5-129.5C (methane to methanol). LR: d (CDC13) 0.83 (6H, t, J = 7 Hz) 1.20-1.42 (4H »m) 1. 96-2. 12 (1H-m) 2.73 (2H * dJ = 6 Hz) 3.25 ( 3H, s) 3.44 (3H, s) 3.86 (3H.s) 3.89 (3H, s) 3.93 (3H.s) 4.04 (3H, s) 6.78-6.90 (3H, ra) 7.73 (lH, s) 14.38 ( lH, s). 1R; υ (CHC13) 2968, 1729, 1606, 1576, 1514, 1489, 1464, 1412, 1139, 1064, 1028 cm -1 ° C3〇H3S〇9 calculation points: C66.65%, H6.71% ; Found: C66.72%, H6. 69%. ί · ί—-If ----------- Dings ^ -5 (Please read the notes on the back before filling in this page) This paper size applies to China National Standard (CNS) A4 specification (210X297 Mm) 83.3.10,000 42066 1 A7 ____B7_ V. Description of the invention () The third example
(請先閲讀背面之注^項再填寫本頁W 合成1-(3,4-二甲氧基苯基)-3-(2-乙基-1-氧丁基)-4-羥 基-2-(甲氧基翔(基)-6,7,8-三甲氧基萘:I-lc。 第1步驟_合成1_(3, 4-二甲氧基苯基>-3-(2-乙基-卜氧 丁基)-1,2-二氫-1,4-二羥基-2-(甲氧基羰基)6,7 , 8-三甲氧基萘:iV-lc。 相同的反應以類似第1例第1步驟的方法進行,自内 酯11-1(第1製備)及不飽和嗣酯I I I-c(第5製備)而得所 要的化合物IV-lc。 熔點:154.5-1 56t:(二氯甲烷-甲醇) ^-NMR: δ (CDC13)0. 19(3Η . J = 7.4Hz) 0.75 (3Η > t, J= 7.4Hz) 1. 13-1.72(4H * m) 2.35-2 . 51 (1H ^ m)3.42 (3H,s)3.65(3H > s)3.79{3H> s)3.86(3H> s)3.94(3H- s) 3.96(1H» s)B.99(3H> s)5.76(lH> s)6.42(lH* άά > J= 8.4Hz» 2.2Hz)6.64(1H > d* J= 8.4Hz) 7 . 14 (1H » d» J = 2.2Hz)7·56(1H , s)。 第2步思合成化合物卜丨c。 經濟部中央標準局員工消费合作杜印策 該反應Μ類似第1例第2步驟之方法進行,自上所製 得之化合物IV-lc開始,而得所要的化合物卜lc。 熔點:113-115^ (丙酮-η-己烷)。(Please read the note ^ on the back before filling in this page. W Synthesis of 1- (3,4-dimethoxyphenyl) -3- (2-ethyl-1-oxybutyl) -4-hydroxy-2 -(Methoxy (yl) -6,7,8-trimethoxynaphthalene: I-lc. Step 1_Synthesis of 1_ (3,4-dimethoxyphenyl > -3- (2- Ethyl-oxobutyl) -1,2-dihydro-1,4-dihydroxy-2- (methoxycarbonyl) 6,7,8-trimethoxynaphthalene: iV-lc. The same reaction starts with The method is similar to the first step of the first example, and the desired compound IV-lc is obtained from the lactone 11-1 (the first preparation) and the unsaturated fluorene ester II Ic (the fifth preparation). Melting point: 154.5-1 56t: (Dichloromethane-methanol) ^ -NMR: δ (CDC13) 0.19 (3Η. J = 7.4Hz) 0.75 (3Η > t, J = 7.4Hz) 1. 13-1.72 (4H * m) 2.35- 2.51 (1H ^ m) 3.42 (3H, s) 3.65 (3H > s) 3.79 (3H > s) 3.86 (3H > s) 3.94 (3H- s) 3.96 (1H »s) B.99 (3H > s) 5.76 (lH > s) 6.42 (lH * άά > J = 8.4Hz »2.2Hz) 6.64 (1H > d * J = 8.4Hz) 7. 14 (1H» d »J = 2.2Hz) 7 · 56 (1H, s). Step 2 Think about the synthesis of compounds 丨 c. Du Yince, the consumer cooperation of the Central Bureau of Standards of the Ministry of Economic Affairs, this reaction is similar to the method in the first step and the second step. The process proceeds from the compound IV-lc prepared above to obtain the desired compound lc. Melting point: 113-115 ^ (acetone-η-hexane).
lH-NMR: δ (CDC13)0.82(3H . t> J=8 Hz)0.83(3H> J=8 Hz) 1.42-1.6〇{2H > n) 1.64-1.81 (2H » m)2.78~ 2·90(1Η,ι〇3·24(3Η, s>3.42(3H,s)3.86(3H, s)3.89(3H 83.3.10,000 本紙張尺度適用中國國家揉準(CNS ) A4規格(2丨0X297公釐) 42Π661 經濟部中央標準局貝工消费合作社印製 A7 B7__五、發明説明() ,s)3.93(3H, s)4.03(3H, s)6.8卜6.87(3Η, β)7·72(1Η ,s>14.18(1Η , s> 。 1R; υ (CHCU) 1730,1606,1575,1523,1490,1463, 1412,1137,1062,1029 公分-1。 Ca9H34〇3之計箕分析:C66.14%,H6.51% ; 發現:C66.09% * H6.64%。 笛4例 合成1-(3, 4-二甲氧基苯基)_4-羥基-2-(甲氧基羰 基)-3-(2-甲基-1-氧代丙基)_6, 7, 8-三丙氧基祭:卜Id 。隹1击思 合成1-(3,4-二甲氧基苯基)-1,2-二氫-1, 4-二羥基-2-(甲氧基羰基3-(2-甲基-1-氧代丙基)-6,7 ,8-三甲氧基萘:IV-ld。 該反應以類似第1例第1步驟的方法進行,自内酯 11-1(第1製備)及不飽和酮酯III-d (第6製備),而得所 要的化合物I V-ld。 熔點:15 5-15613(二氣甲烷_甲醇)。 ^-NMR: δ (CDC13)0.67 (3Η . d* J = 7.0Hz) 1.04 (3Η ,d, J= 6.8Hz) 2. 73-2.88( 1Η . b)3.43{3H^ s)3-67(3H,s) 3.81(3H,s)3.86UH,s〉3.91(1H,s)3.94(3H,s)3.99 (3H,s)5.74(lH,s>6,44(lH,dd,J=8.4Hz,2.0Hz) 6.65(1H> d- J= 8.4Hz)7.14(1H> d » J= 2.0Hz)7.52(1H > s) 〇 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 83. 3. 10,000 42〇β0ι 經濟部中央標準局員工消費合作社印製lH-NMR: δ (CDC13) 0.82 (3H. t > J = 8 Hz) 0.83 (3H > J = 8 Hz) 1.42-1.6〇 {2H > n) 1.64-1.81 (2H »m) 2.78 ~ 2 · 90 (1Η, ι〇3 · 24 (3Η, s > 3.42 (3H, s) 3.86 (3H, s) 3.89 (3H 83.3.10,000 This paper size applies to China National Standard (CNS) A4 specification (2 丨 0X297) (B) 42Π661 Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7__V. Description of the invention (), s) 3.93 (3H, s) 4.03 (3H, s) 6.8b 6.87 (3Η, β) 7.72 ( 1Η, s > 14.18 (1Η, s >.1R; υ (CHCU) 1730, 1606, 1575, 1523, 1490, 1463, 1412, 1137, 1062, 1029 cm-1. Ca9H34〇3 plan analysis: C66. 14%, H6.51%; found: C66.09% * H6.64%. 4 cases of flute synthesis of 1- (3, 4-dimethoxyphenyl) _4-hydroxy-2- (methoxycarbonyl) -3- (2-methyl-1-oxopropyl) _6, 7, 8-tripropoxy sacrifice: Id. 隹 1 think about synthesis of 1- (3,4-dimethoxyphenyl) 1,2,2-dihydro-1,4-dihydroxy-2- (methoxycarbonyl 3- (2-methyl-1-oxopropyl) -6,7,8-trimethoxynaphthalene: IV -ld. This reaction is performed in a similar manner to the first step of the first example, from lactone 11-1 (first preparation) And unsaturated ketoester III-d (preparation 6) to obtain the desired compound I V-ld. Melting point: 15 5-15613 (digas methane_methanol). ^ -NMR: δ (CDC13) 0.67 (3Η. d * J = 7.0Hz) 1.04 (3Η, d, J = 6.8Hz) 2. 73-2.88 (1Η. b) 3.43 (3H ^ s) 3-67 (3H, s) 3.81 (3H, s) 3.86UH , S> 3.91 (1H, s) 3.94 (3H, s) 3.99 (3H, s) 5.74 (lH, s > 6,44 (lH, dd, J = 8.4Hz, 2.0Hz) 6.65 (1H > d- J = 8.4Hz) 7.14 (1H > d »J = 2.0Hz) 7.52 (1H > s) 〇 (Please read the precautions on the back before filling this page) This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 83. 3. 10,000 42〇 β0ι Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs
Α7 Β7_五、發明説明() 第_2_^&_合成化合物I - Id 該反應以類似第1例第2步圏[的方法進行,自上所製 得的化合物IV-ld開始,而得所要的化合物I-ld。 熔酤:108-11〇υ (90%甲醇水溶液)。 ^-NMR: δ (CDC13) 1. 15(3Η » d* J=7 Hz)1.16(3H* d» J=7 Hz)3.09-3.20(lH * m)3.24(3H» s)3.43(3H,s) 3.86(3H, s)3.89(3H, s}3.93(3H, s)4.03(3H, s)6.79 -6.90OH. ·)7.71(1Η. s)13.76(lH· s)〇 1R; υ (nujol)1724, 1604, 1579, 1510, 1410, 1195, 1133 * 1104,1024,988,959,843 公分-1。 CS7H3n〇s計算分析:C65.05%,H6.07% ; 發現:C65. 16%,H6.08%。 第B剜 合成卜(3, 4-二甲氧基苯基卜4-羥基-2-(甲氧基羰 基)-3-U_氧代丙基)-6 * 7,8-三甲氧基萘:I-le。 第1步想 合成卜<3,4-二甲氧基笨基)-1,2-二氫-1,4 -二羥基-2-(甲氧基羰基)-3-U-氧代丙基〉-6, 7, 8-三甲 氧基萘:IV-le。 該反應K類似第2例笫1步驟的方法進行》自内酯 Π-1(第1步驟)及不飽和酮酯丨Π-e(第10製備)開姶,而 得所要的化合物IV-le。 熔點:143-145¾ (甲醇)。 ^-NMR: δ (CDC13)0. 89(BH ^ t* J = 7.4Hz) 2 . 3 1 (2H —-K—1L-----*--装,------訂 (請先閩讀背面之注意事項再填寫本頁) 本紙浪尺度適用中國圉家標準(CNS ) A4規格(210X297公釐} 83.3.10,000 420661 A7 B7 五、發明説明() (請先閱讀背面之注意事項再填寫本頁) ,q. J= 7.4Hz)3.41 (3H . s)3.68(3H» s) 3.82 (3H, s) 3.86 (3H,s)3.87( 1H,s>3,94(3H,s)3.99(3H,s> , 5.73(1H * s)6-44(lH» dd » J=8.4Hz* 2.2Hz) 6.65 (1H » d> J — 8.4Hz)7. 12<1H,d,J = 2.2Hz>7. 51 (1H,s>。 第2步趣 合成化合物I-le。 該反應Μ頚似第1例第2步驟的方法進行,自上所裂 得的化合物IV-le開始,而得化合物I-le。 熔點:145-1461C (乙酸乙酯-二異丙基醚>。 ^-NHR: δ (CDC1 3) 1. 18(3Η - t* J=7.2Hz) 2.81-2.91(2Η> i)3.25(3H> s)3.45(3H. s)3.86(3H» s)3-89 (3H,s)3.93(3H > s)4.03(3H» s)6.80-6.85(3H » m)7.74 (1H,s)14.60(1H,s)。 1R; υ (nujol)1730, 1604, 1577, 1202, 1117* 1023 公 分]°Α7 Β7_V. Description of the invention () _2 _ ^ & _ Synthesis of compound I-Id This reaction is carried out in a similar manner to the first step 2 of step 圏 [, starting from the compound IV-ld prepared above, and The desired compound I-ld is obtained. Melt: 108-110 (90% methanol in water). ^ -NMR: δ (CDC13) 1. 15 (3Η »d * J = 7 Hz) 1.16 (3H * d» J = 7 Hz) 3.09-3.20 (lH * m) 3.24 (3H »s) 3.43 (3H, s) 3.86 (3H, s) 3.89 (3H, s) 3.93 (3H, s) 4.03 (3H, s) 6.79 -6.90OH. ·) 7.71 (1Η. s) 13.76 (lH · s) 〇1R; υ ( nujol) 1724, 1604, 1579, 1510, 1410, 1195, 1133 * 1104, 1024, 988, 959, 843 cm-1. CS7H3nos calculation analysis: C65.05%, H6.07%; found: C65. 16%, H6.08%. Part B: Synthesis of (3, 4-dimethoxyphenyl, 4-hydroxy-2- (methoxycarbonyl) -3-U_oxopropyl) -6 * 7,8-trimethoxynaphthalene : I-le. Step 1 I want to synthesize < 3,4-dimethoxybenzyl) -1,2-dihydro-1,4-dihydroxy-2- (methoxycarbonyl) -3-U-oxopropane Group> -6, 7, 8-trimethoxynaphthalene: IV-le. This reaction K is performed similarly to the method of step 1 in the second example. "The lactone Π-1 (step 1) and unsaturated ketoester 丨 Π-e (preparation 10) are opened to obtain the desired compound IV-le . Melting point: 143-145¾ (methanol). ^ -NMR: δ (CDC13) 0.89 (BH ^ t * J = 7.4Hz) 2. 3 1 (2H —-K—1L ----- *-install, ------ order ( Please read the notes on the back before filling out this page.) The scale of this paper applies to the Chinese family standard (CNS) A4 specification (210X297 mm) 83.3.10,000 420661 A7 B7 V. Description of the invention () (Please read the note on the back first Please fill in this page again), q. J = 7.4Hz) 3.41 (3H. S) 3.68 (3H »s) 3.82 (3H, s) 3.86 (3H, s) 3.87 (1H, s > 3,94 (3H, s) 3.99 (3H, s >, 5.73 (1H * s) 6-44 (lH »dd» J = 8.4Hz * 2.2Hz) 6.65 (1H »d > J — 8.4Hz) 7. 12 < 1H, d, J = 2.2Hz > 7.51 (1H, s >. The second step is to synthesize compound I-le. This reaction is similar to the method of the first step and second step, starting from the compound IV-le obtained above. Compound I-le is obtained. Melting point: 145-1461C (ethyl acetate-diisopropyl ether). ^ -NHR: δ (CDC1 3) 1. 18 (3Η-t * J = 7.2Hz) 2.81- 2.91 (2Η > i) 3.25 (3H > s) 3.45 (3H. S) 3.86 (3H »s) 3-89 (3H, s) 3.93 (3H > s) 4.03 (3H» s) 6.80-6.85 (3H »M) 7.74 (1H, s) 14.60 (1H, s). 1R; υ (nujol) 1730, 1604, 1577, 1202, 1117 * 1023 cm) °
CaBH*e〇3 計算分析:C64.46%,H5.83% ; 發現:C64, 53%,H5. 80%。 經濟部中夬標隼局員工消費合作社印製 第ft例 合成3-(環己烷羰基)-卜<3, 4-二甲氧基苯基〉-4_羥基-2-(甲氧基羰基)-6, 7-甲二氧基禁:I-2a。 第1步!£—合成3-(環己烷羰基卜卜(3, 4-二甲氧基苯基) -1,2-二g-Ι,4-二羥基-2-(甲氧基羰基)-6, 7-甲二氧 基萘:IV-2a。 83. 3. 10,000 本紙浪尺度適用中國國家標準(CNS M4規格(210X297公釐) 經濟部中央標準局貝工消費合作社印製 ^066 1 at ___B7_五、發明説明() 該反應Μ類似第1例第1步班[之方法進行*自内酯 11-2(第2裂備)及不飽和酮醏III-a (第3製備)開姶,而 得所要的化合物IV-2a。 熔酤:193-195X:(二氣甲烷-甲醇) ^-NMR: δ (CDC13)0.90-1.88(10H> «)2.39-2.57 (1Η* β)3.65(3Η» s)3.80(3H» s)3.82(3H* s)4.02(1H> s)4.96(1H,br.s)6.07(2H,s)6.33(1H,dd,J=8.4Hz, 2.2Ηζ)6.62(1Η ^ ά> J= 8.4Hz)6.98(1H . d* J=2.2Hz) 7.20(1H,s)7.45(lH,s〉。 第_2步驟_合成化合物I-2a。 該反應以類似第1例第2步驟之方法進行,自上所製 得的化合物IV-2a開始,而得所要的化合物卜2a。熔酤:177-178*0 (二氧甲烷-甲醇)。 4H-NMR: 8 (CDC13)1.06-1.92(10Η . ι) 2.70-2.88(1Η » β)3.52(3Η» s)3.86(3H> s)3.96(BH* s)6.06(2H> s) 6.77{1Η» s)6.79(lH> d* J = 2.0Hz) 6.82 (1H » dd » J = 8.0Hz» 2.0Hz)6.94 (1H > d· J= 8.0Hz)7.79 (1H · s)13.74 (1H , s) ° 1R; u (CHCU> 1724,1618,1583,1514 * 1450,1241, 1169,1039 公分 *1 ° CaeHa«〇d+算分析:C68.28%,H5_73% ; 發現:C68.05%,H5_77% ° (請先聞旗背面之注$項再填寫本頁) *1T- 本紙張尺度適用中國國家樣準(CNS ) A4規格(210X297公釐) 83.110,000 經濟部中央標隼局員工消費合作社印製 A7 B7 ___五、發明説明() 钜7例 合成卜(3 * 4-二甲氧基苯基)-3-(3-乙基-1-氧代戊基卜4_ 羥基-2_<甲氧基羰基)-6, 7-甲二氧基祭:I-2b。 隹1击睡合成3-(3-7.某-1-氩代戊基)-1-(3,4-二甲氧 基苯基)-1,2-二氫-1,4-二羥基-2-(甲氧基锇基)_6, 7-甲二氧基萘:IV-2b。 該反應Μ類似第2例第1步费[之方法進行,自内酯 11-2(第2裂備)及不飽和酮酯IU-b(第4製備)開始,而 得所要的化合物IV-2b。 熔點:144.5~146.51C < 甲醇)。 ^-NMR: δ (CDC13)0.60-1. 41 (11Η » π) 2 .13 (1H, dd ,J=14.2Hz, 7.0Hz>2.28(lH, dd, J=14.2Hz, 7.0Hz) 3.66(3H* s)3.80(3H> s)3.82(3H> s)3-90(lH- s)4.88 (1H,s)6.07(2H,s>6.39UH,dd,J=8.4Hz,2.2Hz〉 6.63(1H* d> J= 8. 4Hz)6.98(1H . d- J=2.2Hz)7.18 (1H , s)7.48(1H , s)。 笛2进羝合成化合物.I-2b。 該反應K類似第1例第2步驟的方法進行,自上所製 得的化合物IV-2b開姶而得所要的化合物I-2b。 熔點:126-1281C (甲醇)。 UMR:5(CDCl3)0.83(6H,t,J=7.3Hz>1.20-1.42(4Η* π) 1.96-2. 16(1H ^ m)2.73(2H* d,J=6.6Hz) 3.5Π3Η» s)3.86(3H» s)3-96(3H> s)6.06(2H- s)6.72- 420661 (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度逋用中國國家樣準(CNS ) A4規格(210X297公釐) 83.3.10,000 五、發明説明() 6.98(4Η» κ)7.81(1Η» s)14.17(lH> s)〇 1R; u (CHCla)1730,1623,1610,1586,1517’ 1463, 1242,1176,1043 公分 * 1。 (:88(13<»0*計算分析:C68.00%,H6.ll% ; 發現:C67.88%,H6_ 15%。 隹8例 合成1-(3,4-二甲氧基苯基)_4-羥基-2-(甲氧基羰基卜6 ,7-甲二氧基-3-U-氧代丙基)-禁:I-2e。 策1步既合成1-(3,4-二甲氧基苯基)-1,2-二氳-1,4-二羥基-2-(甲氧基羰基卜6,7-甲二氧基-_3-(卜氧代丙基) Μ IV-2e 〇 該反應Μ類似第2例第1步驟的方法進行,自內酯 11-2(第2製備)及不飽和嗣酯ΙΠ-e(第10製備)進行,而 得所要的化合物IV-2e。 熔鲇:138-1401 (甲醇) 經濟部中央標準局員工消費合作杜印製 (請先《讀背面之注意事項再填寫本頁) ^-NMR: δ (CDC13)0.93(3Η - t* J=7.4 Hz) 2.21-2.50{2H. a)3.66(BH» s)3.82(6H> s)3.94(lH- s)4.86 (1H* br . s) 6. 08{2H » s)6.42(lH> dd . J=8.4Hz> 2.2Hz) 6,65(1H. d* J= 8.4Ηζ)6.93(1Η > ά> J= 2.2Hz)7.20(1H ,s)7.45(1H * s)。 第2步铤合成化合物I _2e 該反應K類似第1例第2步驟的方法進行,自上所製 本纸張尺度適用中國國家榇準(CNS ) Α4規格(210X297公釐) S3. 3.10,000 420661 經濟部中央標隼局貝工消費合作社印製 A7 B7 _五、發明説明() 得的化合物IV-2e開始,而得所要的化合物I-2e。 熔點:169-170¾ (二氣甲烷-甲醇〉 ^H-NMR: δ (CDC13) 1. 19(3Η * J=7.2 Hz) 2.81- 2.9K2H· »)3.52(3H> s)3.86(3H» s)3.95(3H· s)6.06 (2H » s)6.72(lH> s) 6.79-6.92 (BH - m)7.81(lH> s)14.36 (1H , s)。 1R; υ (CHCM 1724,1619,1582,1459,1175,103S* 1025 公分―1。 算分析:C65.75%,H5.06% ; 發現;C65. 55%,Η5· 14%。 第9例 使用甲烷磺酸作為脫水劑之製備第2例之化合物卜lb。 会成化会物I -1 b 將甲磺酸(1.15克〉加至於第2例第1步驟製備的5. 58 克(10.0毫契耳)化合物IV-lb在23ml乾乙腈的懸浮液中, 在室溫中攪拌該混合物1小時又15分鐘。在該反應溶液中 加入24b1的水,在冰浴冷卻下搜拌該混合物30分鐘。K過 濾收集沈锻的結晶。自丙酮-甲醇中再結晶化該晶體2次 ,而得所要化合物1-比5.04克(93%)。 熔點:128-129T:。 此化合物之所有其他物理性質和第2例的化合物一致 〇 上述實列所製備的化合物列於下列的表。 (請先W讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) 83. 3.10,000 ^ 2 Ο 6' 6 1 Α7 Β7 五、發明説明() 第1表 OH Ο MeO六 Me〇 Q OMe omb (第1例) 丨_ia;Ri= (第2例) b;R1 = -CH2CHEt2 (第3例) c; R1=-CHEt2 (第4例) d; R1 =-CHMe2 (第5例) e; R1 =-Et 第2表. — J--- *― i --裝-------訂 (讀先鬩讀背面之注意事項再填寫本頁) 經濟部t央標準局員工消費合作社印製 OH ΟCaBH * e〇3 calculation analysis: C64.46%, H5.83%; found: C64, 53%, H5. 80%. Printed by the Consumers' Cooperative of the Ministry of Economic Affairs and Standards Bureau of the People's Republic of China on Synthesis of 3- (Cyclohexanecarbonyl)-<3,4-dimethoxyphenyl> -4_hydroxy-2- (methoxy Carbonyl) -6, 7-methoxyloxy: I-2a. step 1! £ —synthesis of 3- (cyclohexanecarbonylb (3,4-dimethoxyphenyl) -1,2-dig-1,4-dihydroxy-2- (methoxycarbonyl) -6, 7-Methylenedioxynaphthalene: IV-2a. 83. 3. 10,000 This paper is in accordance with Chinese National Standards (CNS M4 (210X297 mm)) Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ^ 066 1 at ___B7_ V. Description of the invention () The reaction M is similar to the method of the first step of the first case [* from the lactone 11-2 (the second split preparation) and the unsaturated ketone III-a (the third preparation). The desired compound IV-2a is obtained. Melt: 193-195X: (digas methane-methanol) ^ -NMR: δ (CDC13) 0.90-1.88 (10H > «) 2.39-2.57 (1Η * β) 3.65 (3Η »S) 3.80 (3H» s) 3.82 (3H * s) 4.02 (1H > s) 4.96 (1H, br.s) 6.07 (2H, s) 6.33 (1H, dd, J = 8.4Hz, 2.2Ηζ) 6.62 (1Η ^ ά > J = 8.4Hz) 6.98 (1H. D * J = 2.2Hz) 7.20 (1H, s) 7.45 (lH, s). Step _2_Synthesis of compound I-2a. The method of the second step of one case was performed, starting from the compound IV-2a prepared above, and the desired compound BU 2a was obtained. Melting point: 177-178 * 0 (dioxymethane-methanol). 4H-NMR: 8 (CDC13) 1.06-1.92 (10Η. Ι) 2.70-2.88 (1Η »β) 3.52 (3Η» s) 3.86 (3H > s) 3.96 (BH * s) 6.06 (2H > s) 6.77 (1Η »s) 6.79 (lH > d * J = 2.0Hz) 6.82 (1H »dd» J = 8.0Hz »2.0Hz) 6.94 (1H > d · J = 8.0Hz) 7.79 (1H · s) 13.74 (1H, s) ° 1R; u (CHCU > 1724, 1618, 1583, 1514 * 1450, 1241, 1169, 1039 cm * 1 ° CaeHa «〇d + calculation analysis: C68.28%, H5_73%; Discovery: C68.05%, H5_77% ° (Please fill in this page with the note “$” on the back of the flag) * 1T- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 83.110,000 Printed by the Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs A7 B7 ___ V. Explanation of the invention () 钜 7 cases of synthesis (3 * 4-dimethoxyphenyl) -3- (3-ethyl-1-oxopentylbu 4_hydroxy-2_ < methoxy Carbonyl) -6, 7-methyldioxyl: I-2b.隹 1 knockdown to synthesize 3- (3-7.-1-1-argonpentyl) -1- (3,4-dimethoxyphenyl) -1,2-dihydro-1,4-dihydroxy -2- (methoxyfluorenyl) -6,7-methoxydioxynaphthalene: IV-2b. This reaction M is performed similarly to the method of the first step in the second example, starting from lactone 11-2 (second split preparation) and unsaturated ketoester IU-b (the fourth preparation), and obtaining the desired compound IV- 2b. Melting point: 144.5 ~ 146.51C < Methanol). ^ -NMR: δ (CDC13) 0.60-1. 41 (11Η »π) 2 .13 (1H, dd, J = 14.2Hz, 7.0Hz > 2.28 (lH, dd, J = 14.2Hz, 7.0Hz) 3.66 ( 3H * s) 3.80 (3H > s) 3.82 (3H > s) 3-90 (lH- s) 4.88 (1H, s) 6.07 (2H, s > 6.39UH, dd, J = 8.4Hz, 2.2Hz> 6.63 (1H * d > J = 8. 4Hz) 6.98 (1H. D- J = 2.2Hz) 7.18 (1H, s) 7.48 (1H, s). Flute 2 enters the compound. I-2b. The reaction K is similar The method of the first step and the second step is carried out, and the desired compound I-2b is obtained from the compound IV-2b prepared above. Melting point: 126-1281C (methanol). UMR: 5 (CDCl3) 0.83 (6H, t, J = 7.3Hz > 1.20-1.42 (4Η * π) 1.96-2. 16 (1H ^ m) 2.73 (2H * d, J = 6.6Hz) 3.5Π3Η »s) 3.86 (3H» s) 3-96 (3H > s) 6.06 (2H- s) 6.72- 420661 (Please read the precautions on the back before filling out this page) This paper size uses the Chinese National Standard (CNS) A4 specification (210X297 mm) 83.3.10,000 V. Description of the invention () 6.98 (4Η »κ) 7.81 (1Η» s) 14.17 (lH > s) 〇1R; u (CHCla) 1730, 1623, 1610, 1586, 1517 '1463, 1242, 1176, 1043 cm * 1. (: 88 (13 < »0 * calculation analysis: C68.00%, H6.ll% Found: C67.88%, H6_15%. 隹 8 cases of synthesis of 1- (3,4-dimethoxyphenyl) _4-hydroxy-2- (methoxycarbonyl group 6,7-methoxydioxy -3-U-oxopropyl) -prohibited: I-2e. 1- (3,4-dimethoxyphenyl) -1,2-difluorene-1,4-dihydroxy -2- (methoxycarbonyl bu 6,7-methyldioxy-_3- (oxopropyl) M IV-2e 〇 This reaction M is similar to the method of the first step of the second example, from lactone 11 -2 (preparation 2) and unsaturated ethyl ester III-e (preparation 10) to obtain the desired compound IV-2e. Melting point: 138-1401 (methanol) Employees' cooperation cooperation with Central Standards Bureau, Ministry of Economic Affairs (Please read the “Notes on the back side before filling out this page”) ^ -NMR: δ (CDC13) 0.93 (3Η-t * J = 7.4 Hz) 2.21-2.50 {2H. A) 3.66 (BH »s) 3.82 ( 6H > s) 3.94 (lH- s) 4.86 (1H * br. S) 6. 08 (2H »s) 6.42 (lH > dd. J = 8.4Hz > 2.2Hz) 6,65 (1H. D * J = 8.4Ηζ) 6.93 (1Η > J = 2.2Hz) 7.20 (1H, s) 7.45 (1H * s). Step 2 铤 Synthesis of compound I _2e The reaction K is similar to the method in Step 2 of Example 1. The paper size prepared from the above applies to China National Standard (CNS) A4 (210X297 mm) S3. 3.10,000 420661 Printed by the Central Bureau of Standards, Ministry of Economic Affairs, Shellfish Consumer Cooperative, A7 B7 _V. Description of the Invention () The compound IV-2e is obtained, and the desired compound I-2e is obtained. Melting point: 169-170¾ (digas methane-methanol> ^ H-NMR: δ (CDC13) 1. 19 (3Η * J = 7.2 Hz) 2.81- 2.9K2H · ») 3.52 (3H > s) 3.86 (3H» s ) 3.95 (3H · s) 6.06 (2H »s) 6.72 (lH > s) 6.79-6.92 (BH-m) 7.81 (lH > s) 14.36 (1H, s). 1R; υ (CHCM 1724, 1619, 1582, 1459, 1175, 103S * 1025 cm -1. Calculation analysis: C65.75%, H5.06%; found; C65. 55%, Η5.14%. Ninth case 58 g (10.0) methanesulfonic acid (1.15 g) was added to 5.58 g (10.0) prepared in the first step of the second example using methanesulfonic acid as a dehydrating agent to prepare the compound lb of the second example. Millicel) Compound IV-lb in a suspension of 23 ml of dry acetonitrile, and the mixture was stirred at room temperature for 1 hour and 15 minutes. To the reaction solution was added 24b1 of water, and the mixture was searched under ice-cooling for 30 Min. K collected the forged crystals by filtration. The crystals were recrystallized twice from acetone-methanol to obtain the desired compound 1-5.04 g (93%). Melting point: 128-129T :. All other physical properties of this compound The properties are the same as those of the compound of Example 2. The compounds prepared in the above examples are listed in the following table. (Please read the precautions on the back before filling this page.) This paper size applies the Chinese National Standard (CNS) A4 specification (210X29). ? Mm) 83. 3.10,000 ^ 2 Ο 6 '6 1 Α7 Β7 V. Description of the invention () Table 1 OH 〇 MeO 六Me〇Q OMe omb (1st case) 丨 _ia; Ri = (2nd case) b; R1 = -CH2CHEt2 (3rd case) c; R1 = -CHEt2 (4th case) d; R1 = -CHMe2 ( (Example 5) e; R1 = -Et Table 2. — J --- * ― i-equipment ------- order (read the precautions on the reverse side and then fill out this page) Ministry of Economic Affairs t Printed by the Central Standards Bureau's Consumer Cooperatives OH Ο
C 第 6 例)丨-23;^= — (第 7 例) b; R1 = - CH2CHEt2 (第 8 例) e: R1 = - 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) 83. 3, 10,000 經濟部中央橾準局貝工消費合作社印製 420661 A7 ______B7_五、發明説明() 發萌^物用 使用第1及第2例所得的化合物進行藥理試驗。 蕖1 a賒 對LDL氧化修改作用之抑制作用。 測試好詳ft方法 依據描述於Proceedings of the National Academy of Sciences,USA,第 84 組,5928 頁( 1987>Kita 等人之方 法1如下地進行試驗。 首先,自餵食含0.5%腔固醇的飼料三週的紐西鬨白 兔中分離LDL *及溶於磷酸鹽缓衝的生理食鹽水中(最终 LDL濃度:0.2mg蛋白質/ ml)。對此加入每個測試化合物 的乙醇溶液,然後加入硫酸銅(最終Cu2 +濃度:〇.5w M)及 將該混合物在37¾培餐24小時。 以作為硫代巴比土酸反應物質(TBA反應性物質)來測 量在每値培餐溶液中的脂肪遇氧化物的量,及自LDL氧化 修飾作用的抑制速率的回歸線及該化合物的濃度而計算50 %抑制濃度(ICee)。TBA反應性物質之定量測定是MTBA 方法之測量上淸液(以自該培養溶液除去蛋白質而製備〉之 TBA反應性物質而進行。 结果顯示於如下之第3表。 依本發明方法所得化合物之ICa。數值不超過1〇μΜ, 因而該化合物據了解對LDL顯示強的抗氧化作用。 第2式驗 降低膝固醇之作用。 (請先閲讀背面之注意事項再填寫本頁) -訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 41 83.3. !〇,〇〇〇 420661 A7 B7 五、發明説明( 潮試及評估方法 雄性ICR鼠(髏重:30-40克)自由餵食含1 %膽固醇 ,0.5%瞻酸納及添加0.12%測試化合物(對照組不添加此 化合物)之飼料7天,收集鼠之血液,及用描述於Clinical Chemistry第20期,470頁(1974)Allain之方法潮量血清總 胯固醇。 VLDL膽固醇及LDL瞻固醇的總量是由自總膽固醇量 中滅去HDL瞻固醇Μ而計算得。HDL膽固醇的量是以描述 於Clinical Chemistry 第24期,2180頁(1978)的ASH 及 Hentschel方法測量而得。 測試化合物之降低瞻固醇的作用是自下列程式計算得 的瞻固醇降低速率來評估的。 缠腰固醇降低速率=(卜〔(在測試化合物组中之缠瞻固 醇)/(在對照組中之總臛固醇} X100 (VLDL+LDL >膽固醇降低速率=U-〔(在測試化合物組 中之VLDL + LDL胺固醇)/ (在對照組中之VLDL+LDL膝固 醇)〕} X 100 結果顯示於第3表。 讀 先 聞 讀 背 面 之 注 項 填 .在 頁 訂 經濟部中央標隼局負工消費合作社印製 本紙張尺度逍用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3.10,000 4^β6\ Α7 Β7 五、發明説明() 第3表 實例 LDL-氧化抑制 缠檐固醇 (VLDL+ LDL) ICe〇 { u Μ) 降低速率 (96) 胺固醇降低速率 {% ) 1 0.46 22 61 2 0.40 35 72 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局貝工消費合作社印製 二偁化合物都顯示對(VLDL+LDL )膽固醇之優良的 降低作用,但並未顯示在HDL瞻固醇之降低,因此,本發 明所得之化合物據了解顯示強及選擇性的降低膜固醇作用 本紙張尺度適用中國國家標準(CNS ) A4C格(210X297公釐) 83. 3. 10,000C 6th example) 丨 -23; ^ = — (7th case) b; R1 =-CH2CHEt2 (8th case) e: R1 =-This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 83. 3, 10,000 Printed by Shelley Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs, 420661 A7 ______B7_V. Description of Invention () Germination ^ Pharmacological tests were performed using the compounds obtained in the first and second cases.蕖 1a credit inhibits the oxidative modification of LDL. The test method is based on the method described in Proceedings of the National Academy of Sciences, USA, Group 84, p. 5928 (1987 & Kita et al. Method 1). The test is performed as follows. First, a 0.5% cavity-sterol-containing feed is self-fed Three weeks of New Zealand coaxed LDL * from white rabbits and dissolved in phosphate buffered saline (final LDL concentration: 0.2 mg protein / ml). To this was added an ethanol solution of each test compound, and then copper sulfate. (Final Cu2 + concentration: 0.5 wM) and the mixture was cultured at 37¾ for 24 hours. As a thiobarbituric acid-reactive substance (TBA-reactive substance), the fat content in each dietary solution was measured. The amount of oxides, and the regression line from the inhibition rate of LDL oxidation modification and the concentration of the compound were used to calculate the 50% inhibition concentration (ICee). The quantitative determination of TBA-reactive substances is the MTBA method to measure the upper liquid (from The culture solution was prepared by removing the TBA-reactive substance from the protein. The results are shown in Table 3 below. The ICa of the compound obtained according to the method of the present invention. The value does not exceed 10 μM. It is understood that the compound shows a strong antioxidant effect on LDL. Type 2 test reduces the effect of knee sterol. (Please read the precautions on the back before filling out this page)-The size of the paper is applicable to the Chinese National Standard (CNS) A4 Specifications (210X297 mm) 41 83.3.! 〇, 〇〇〇420661 A7 B7 V. Description of the invention (Tidal test and evaluation method Male ICR rats (skeleton weight: 30-40 g)) Free feeding with 1% cholesterol, 0.5% Sodium acid and feed with 0.12% test compound (control group did not add this compound) for 7 days, blood was collected from rats, and total serum volume was stabilized by the method described in Clinical Chemistry No. 20, p. 470 (1974) Allain The total amount of VLDL cholesterol and LDL sterol is calculated by eliminating HDL sterol M from total cholesterol. The amount of HDL cholesterol is described in Clinical Chemistry Issue 24, page 2180 (1978) Measured by the ASH and Hentschel methods. The effect of the test compound on reducing the sterol was evaluated from the sterol reduction rate calculated from the following formula. Waist sterol reduction rate = (Bu [(in the test compound group Entangled sterol) / ( Total testosterone in the control group} X100 (VLDL + LDL > Cholesterol reduction rate = U-[(VLDL + LDL steroid in the test compound group) / (VLDL + LDL knee solid in the control group The results are shown in Table 3. Read the first note and read the note on the back. On the page, order the paper printed by the Central Bureau of Standards, Ministry of Economic Affairs, Consumer Cooperatives, and use the paper size of China National Standard (CNS) A4 (210X297 mm). 83. 3.10,000 4 ^ β6 \ Α7 Β7 V. Explanation of the invention () Example of Table 3 LDL-oxidation inhibition enamel sterol (VLDL + LDL) ICe〇 {u Μ) Decrease rate (96) Aminosterol decrease rate (%) 1 0.46 22 61 2 0.40 35 72 (Please read the notes on the back before filling out this page) The dihydrazone compounds printed by the Shellfish Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economics have shown excellent reduction of (VLDL + LDL) cholesterol, but they are not shown in HDL observes the reduction of sterols. Therefore, it is understood that the compounds obtained by the present invention show strong and selective reduction of membrane sterols. This paper is applicable to China National Standard (CNS) A4C (210X297 mm). 83. 3. 10,000
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8994693 | 1993-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW420661B true TW420661B (en) | 2001-02-01 |
Family
ID=13984877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW83103282A TW420661B (en) | 1993-04-16 | 1994-04-13 | Preparation of lignan analogues |
Country Status (6)
Country | Link |
---|---|
CN (2) | CN1104622A (en) |
AU (2) | AU672095B2 (en) |
CA (1) | CA2121060C (en) |
HU (1) | HU211086B (en) |
NO (2) | NO302815B1 (en) |
TW (1) | TW420661B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO170760C (en) * | 1985-01-10 | 1992-12-02 | Tanabe Seiyaku Co | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE NAPHENSE DERIVATIVES |
US5003087A (en) * | 1989-02-03 | 1991-03-26 | Tanabe Seiyaku Co., Ltd. | Process for preparing a naphthalene derivative and a synthetic intermediate thereof |
WO1994024087A1 (en) * | 1993-04-16 | 1994-10-27 | Shionogi & Co., Ltd. | Process for producing lignan compound |
-
1994
- 1994-04-12 CA CA 2121060 patent/CA2121060C/en not_active Expired - Fee Related
- 1994-04-13 TW TW83103282A patent/TW420661B/en active
- 1994-04-14 AU AU59481/94A patent/AU672095B2/en not_active Ceased
- 1994-04-15 NO NO941382A patent/NO302815B1/en unknown
- 1994-04-15 HU HU9401085A patent/HU211086B/en not_active IP Right Cessation
- 1994-04-15 CN CN 94105557 patent/CN1104622A/en active Pending
-
1996
- 1996-12-13 AU AU75339/96A patent/AU685716B2/en not_active Ceased
-
1998
- 1998-01-09 NO NO19980102A patent/NO317062B1/en unknown
-
2000
- 2000-07-25 CN CN 00122210 patent/CN1285352A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
NO302815B1 (en) | 1998-04-27 |
NO317062B1 (en) | 2004-08-02 |
HU211086B (en) | 1995-10-30 |
CA2121060A1 (en) | 1994-10-17 |
CN1104622A (en) | 1995-07-05 |
NO941382D0 (en) | 1994-04-15 |
NO980102D0 (en) | 1998-01-09 |
HUT66861A (en) | 1995-01-30 |
HU9401085D0 (en) | 1994-07-28 |
AU7533996A (en) | 1997-02-13 |
NO980102L (en) | 1998-01-09 |
AU685716B2 (en) | 1998-01-22 |
AU5948194A (en) | 1994-10-20 |
CN1285352A (en) | 2001-02-28 |
CA2121060C (en) | 2004-04-06 |
AU672095B2 (en) | 1996-09-19 |
NO941382L (en) | 1994-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4452813A (en) | Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative | |
JP3411036B2 (en) | Method for producing lignan compound | |
EP0032063B1 (en) | Novel substituted arylene compounds and processes for their production | |
NO174292B (en) | Analogous procedure for the preparation of a therapeutically active quinone derivative | |
JP2013533267A (en) | Method for preparing benzofuran derivative substituted at 5-position | |
HUT73763A (en) | Endothelin receptor antagonists, pharmaceutical compositions contg.them and process to prepare them | |
JPH01242570A (en) | Isoquinolines | |
KR20020033617A (en) | Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof | |
TW420661B (en) | Preparation of lignan analogues | |
Yadav et al. | Titanium (III) mediated regiospecific reduction of vinyl epoxides | |
NITTA et al. | Synthesis and structures of 6-aryl-1, 5-dimethoxycarbonyl-2-methyl-4-morpholino-1, 3-cyclohexadienes and related compounds | |
US5696271A (en) | Process for the preparation of 3-isoxazolecarboxylic acid | |
JPS609490B2 (en) | Production method of cyclohexanedione-(1,3) | |
JPH03115274A (en) | Beta-lactone derivative and remedy for hyperchole-steremia containing the same | |
US5359054A (en) | Initial compounds for the production of 10β-H-steroids and a process for the production of these initial compounds | |
JP6256469B2 (en) | Process for the preparation of spiro [2.5] octane-5,7-dione | |
WO1994006785A1 (en) | Novel sulfonic acide derivative and medicinal use thereof | |
US3284505A (en) | 19-nor-b-nortestosterones | |
WO1992013821A1 (en) | Bicyclo[4.1.0]heptane-2,4-dione derivative, intermediate for the synthesis thereof, and production thereof | |
JP3467072B2 (en) | Preparation of lignan analogs | |
JPS60142976A (en) | Isocoumarin derivative | |
US2891995A (en) | Steroid intermediates and synthesis thereof | |
JP3097678B2 (en) | Aphanorphin intermediate | |
NO751362L (en) | ||
US5104995A (en) | 4-(3,3-ethylenedioxo- cyclohexyl) acetophenone and derivatives thereof, processes for preparing them and use of these compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent |